US Pre-Market SEC Filings Roundup — December 17, 2025

17-12-2025

Inspirato Inc filed an 8-K on December 17, 2025, disclosing Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the core event, transaction value, or financial metrics are provided in the filing summary. This is a multi-item voluntary disclosure with limited disclosed information.

• ·Items reported: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item filing; Item 8.01 is voluntary for material events not covered elsewhere
• ·No quantitative data (e.g., transaction value, share count, financial metrics) disclosed

17-12-2025

VERU INC. filed an 8-K on December 17, 2025, disclosing Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction details, or quantitative data are provided in the filing summary. Analysis is limited to filing structure with all key impacts NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 2.02 and 9.01
• ·Voluntary disclosure of financial results
• ·No revenue, earnings, or balance sheet details extracted (all NOT_DISCLOSED)

17-12-2025

Netflix welcomes the Warner Bros. Discovery (WBD) Board's recommendation for stockholders to approve its $82.7 billion merger agreement, valued at $27.75 per WBD share in cash and stock, over a rival unsolicited offer from Paramount Skydance (PSKY). The deal includes the planned Q3 2026 separation of WBD's Discovery Global business, providing additional stockholder value. Netflix emphasizes superior financing certainty, regulatory confidence, and operational flexibility compared to the PSKY bid.

• ·WBD Board urges stockholders to reject PSKY's offer and approve Netflix merger after advisor review.
• ·Transaction valued at $27.75 per WBD share ($23.25 cash + $4.50 Netflix stock), total equity value $72 billion.
• ·Includes separation of Discovery Global for enhanced value; expected close in 12-18 months.
• ·Netflix highlights committed financing, $5.8B reverse termination fee, and no CFIUS risks versus PSKY uncertainties.

17-12-2025

INVO Fertility, Inc. filed a Form 8-K on December 17, 2025, disclosing entry into a Material Definitive Agreement (Item 1.01), Other Events (Item 8.01), and Financial Statements and Exhibits (Item 9.01). No specific details on the agreement, transaction value, or financial impacts are provided in the filing summary. This multi-item filing signals a potentially significant corporate development but lacks quantitative data for assessment.

• ·Multi-item 8-K filing: Items 1.01, 8.01, 9.01
• ·Core event: Entry into Material Definitive Agreement (NOT_DISCLOSED details)
• ·Filed timely per metadata (exact timing NOT_DISCLOSED)

17-12-2025

ManpowerGroup Inc. filed a multi-item 8-K on December 17, 2025, reporting entry into a new material definitive agreement (Item 1.01), termination of a prior material definitive agreement (Item 1.02), creation of a direct financial obligation (Item 2.03), other events (Item 8.01), and exhibits (Item 9.01). No specific details, transaction values, or financial impacts are disclosed in the provided filing summary. Analysis is limited to item disclosures, indicating potential refinancing or restructuring activity.

• ·Multi-item mandatory 8-K filing: Items 1.01, 1.02, 2.03, 8.01, 9.01
• ·Core events: Entry/termination of material agreements and new financial obligation; all quantitative data (e.g., transaction value, share count) NOT_DISCLOSED
• ·Timing and filing compliance not specified; exhibits likely contain details

17-12-2025

Traws Pharma, Inc. filed an 8-K on December 17, 2025, disclosing under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the core event, transaction, or financial metrics are provided in the filing summary. Analysis is limited due to lack of explicit content.

• ·Multi-item 8-K filing: Items 8.01 and 9.01
• ·Filed same day as event date (2025-12-17); compliance with 4-business-day rule cannot be assessed without event timing
• ·All quantitative data (transaction value, shares, financial metrics) NOT_DISCLOSED

17-12-2025

MAIA Biotechnology, Inc. filed an 8-K on December 17, 2025, reporting under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific transaction details, values, or financial metrics are disclosed in the provided summary. Analysis is limited to filing items; all quantitative data is NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 1.01, 3.02, 8.01, 9.01
• ·Indicates entry into material definitive agreement and unregistered equity sales
• ·Filed same day as event date; compliance with 4-business-day window cannot be assessed without full filing

17-12-2025

Quantum Computing Inc. filed an 8-K on 2025-12-17 disclosing an officer or director change under Item 5.02, with exhibits under Item 9.01. No specifics on position, individual, reason, or quantitative details provided in the filing summary. Event type indicates potential leadership transition but lacks material facts for deeper analysis.

• ·Item 5.02: Departure, election, or appointment of directors/officers or compensatory arrangements
• ·Item 9.01: Financial statements and exhibits filed (320 KB)
• ·No names, positions, reasons, or quantitative data (e.g., shares, values) disclosed

17-12-2025

Brag House Holdings, Inc. filed an 8-K on December 17, 2025, reporting Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year) and Item 9.01 (Financial Statements and Exhibits). No specific details on the amendments, fiscal year change, or exhibits are disclosed in the provided summary. Analysis is limited to item descriptions; all transaction values, financial metrics, and impacts are NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 5.03 and 9.01 reported.
• ·Core event: Amendments to governance documents or fiscal year change (details NOT_DISCLOSED).
• ·No quantitative data (e.g., dollar values, share counts) or financial impacts mentioned.

17-12-2025

Escalade Inc filed an 8-K on December 17, 2025, disclosing under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits). No specific details on the events, transactions, or exhibits are provided in the filing summary. Analysis is limited due to lack of substantive content.

• ·Multi-item 8-K filing: Items 8.01 and 9.01 only.
• ·Item 8.01 indicates unspecified 'Other Events'; Item 9.01 references unspecified exhibits.
• ·No quantitative data, core event details, or financial metrics disclosed.

17-12-2025

8-K filing dated 2025-12-17 discloses amendments to articles of incorporation or bylaws/change in fiscal year (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01), tagged as a Merger/Acquisition event. No specific parties, deal structure, valuation, or quantitative details are provided in the summary. Critical information such as acquirer, target, transaction value, and strategic rationale is NOT_DISCLOSED.

• ·Event Type: Merger/Acquisition announced under Items 5.03 and 8.01
• ·No parties, deal size, consideration type, or financial metrics disclosed
• ·Exhibits filed under Item 9.01, but contents NOT_DISCLOSED

17-12-2025

Mawson Infrastructure Group Inc. filed an 8-K on December 17, 2025, under Item 8.01 Other Events. No core event details, transaction values, or financial metrics are disclosed in the provided filing summary. Analysis is severely limited by absence of substantive content.

• ·Single-item 8-K filing: Item 8.01 (Other Events).
• ·Voluntary disclosure; timing compliance unknown but filed on event date.
• ·All quantitative data (transaction value, shares, financial metrics) = NOT_DISCLOSED.

17-12-2025

Marwynn Holdings, Inc. filed an 8-K on December 17, 2025, disclosing Item 5.07 regarding submission of matters to a vote of security holders. No specific details on the matters voted on, outcomes, or quantitative data are provided in the filing summary. This appears to be a routine, mandatory disclosure of shareholder vote results.

• ·Specific Item reported: 5.07 (Submission of Matters to a Vote of Security Holders)
• ·Single-item filing
• ·No transaction values, share counts, or financial metrics disclosed
• ·Core event: Shareholder vote submission (details NOT_DISCLOSED)

17-12-2025

YHN Acquisition I Ltd filed an 8-K on December 17, 2025, disclosing entry into a material definitive agreement (Item 1.01) likely related to a merger/acquisition, with financial statements and exhibits attached (Item 9.01). No specific details on parties, structure, valuation, or terms are provided in the summary. Sector not specified, limiting analysis depth.

• ·Item 1.01 confirms entry into Material Definitive Agreement
• ·Item 9.01 includes Financial Statements and Exhibits (contents NOT_DISCLOSED)
• ·All quantitative data (transaction value, shares, percentages, financial metrics) NOT_DISCLOSED

17-12-2025

NeuroOne Medical Technologies Corp filed a Form 8-K on December 17, 2025 (AccNo: 0001213900-25-122541), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. No specific financial metrics, transaction values, or numerical data are disclosed in the provided filing summary. Analysis is limited to filing structure due to absence of detailed content.

• ·Items 2.02 and 9.01 reported; multi-item filing
• ·Financial results announcement; quantitative data (revenue, EPS, etc.) NOT_DISCLOSED
• ·Compliance with SEC 8-K requirements presumed; timing and details NOT_DISCLOSED

17-12-2025

Zura Bio Ltd filed a Form 8-K on December 17, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements). No specific details on the officer's position, name, appointment/resignation status, reasons, or quantitative data are provided in the summary. Analysis is limited due to lack of explicit filing content.

• ·Item 5.02 officer change disclosure filed 2025-12-17
• ·AccNo: 0001104659-25-121826, Size: 193 KB
• ·Sector not specified; no quantitative data (e.g., shares, values: NOT_DISCLOSED)

17-12-2025

NerdWallet, Inc. filed an 8-K on December 17, 2025, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the disclosure content, events, or financial data are provided in the filing summary. This appears to be a multi-item voluntary disclosure with attached exhibits.

• ·Specific Items: 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item filing; timing compliance NOT_DISCLOSED
• ·Core event, financial impacts, and quantitative data all NOT_DISCLOSED

17-12-2025

filed 8-K/A on December 17, 2025 - Filed: 2025-12-17 AccNo: 0001766400-25-000147 Size: 926 KB Item 9.01: Financial Statements and Exhibits

• ·Filing Type: 8-K/A
• ·Priority: MEDIUM
• ·Filed: 2025-12-17 AccNo: 0001766400-25-000147 Size: 926 KB Item 9
• ·01: Financial Statements and Exhibits

17-12-2025

Steel Dynamics Inc filed a Form 8-K on December 17, 2025, under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). No specific event details, financial metrics, or transaction data are disclosed in the provided filing summary. This appears to be a multi-item voluntary disclosure compliant with Reg FD timing requirements.

• ·Specific Items: 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item filing; timing aligns with filing date (within standard 4 business days for 8-K)
• ·Voluntary disclosure under Reg FD; exhibits likely attached but content NOT_DISCLOSED

18-12-2025

Allstate Corp filed an 8-K on December 18, 2025, reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the content of the disclosure or exhibits are provided. Quantitative data and event specifics are NOT_DISCLOSED.

• ·Specific Items: 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits); multi-item filing.
• ·Voluntary disclosure under Reg FD; timing compliance cannot be assessed without event date.
• ·Core event, financial impact, and materiality NOT_DISCLOSED due to lack of filing content.

17-12-2025

Vivos Therapeutics, Inc. filed a Form 8-K on December 17, 2025, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No details on the specific events, transactions, or exhibits are provided in the filing summary. This is a multi-item filing with limited disclosed information.

• ·Reported Items: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item filing; core event details NOT_DISCLOSED
• ·Quantitative data (transaction value, share count, financial metrics) all NOT_DISCLOSED

17-12-2025

News Corp filed a Form 8-K on December 17, 2025, reporting Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the events, transactions, or exhibits are disclosed in the provided filing summary. All quantitative data such as transaction values, share counts, or financial metrics are NOT_DISCLOSED.

• ·Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits) reported; multi-item filing
• ·Voluntary disclosure likely for Item 8.01; timing compliance unknown
• ·No core event, financial impact, or materiality details provided

17-12-2025

Finance of America Companies Inc. filed an 8-K on December 17, 2025, reporting entry into a material definitive agreement (Item 1.01), material modifications to rights of security holders (Item 3.03), amendments to articles of incorporation or bylaws (Item 5.03), and financial statements/exhibits (Item 9.01). This is a multi-item filing with no specific transaction details, dollar values, or quantitative impacts disclosed in the provided summary. Analysis is limited to reported items only.

• ·Multi-item 8-K filing covering Items 1.01, 3.03, 5.03, and 9.01.
• ·Core events: Entry into material definitive agreement; modifications to security holder rights; governance amendments.
• ·No numerical data (e.g., transaction value: NOT_DISCLOSED; share count: NOT_DISCLOSED; financial metrics: NOT_DISCLOSED)

17-12-2025

Coya Therapeutics, Inc. filed an 8-K on December 17, 2025, reporting under Item 8.01 Other Events (Accession No. 0001193125-25-321737, size 139 KB). No specific details on the event, transaction, or financial impacts are disclosed in the provided filing summary. Analysis is limited to metadata, with all quantitative and event-specific data marked as NOT_DISCLOSED.

• ·Item 8.01: Other Events reported
• ·Filing date: 2025-12-17, single-item 8-K
• ·Sector not specified; no quantitative data (e.g., transaction value, share count: NOT_DISCLOSED)

17-12-2025

Mercantile Bank Corp filed a Form 8-K on December 17, 2025, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No details on the specific event, transaction, financials, or exhibits are disclosed in the provided summary. Analysis is limited to filing structure; all event and quantitative data are NOT_DISCLOSED.

• ·Items reported: 8.01 (Other Events, voluntary) and 9.01 (Exhibits, mandatory if applicable)
• ·Multi-item filing; timing compliance and core event details NOT_DISCLOSED
• ·No quantitative data (transaction value, shares, metrics: all NOT_DISCLOSED)

17-12-2025

Dynatronics Corp filed an 8-K on December 17, 2025, reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific vote details, outcomes, or numerical data are disclosed in the provided filing summary. This is a single-item, mandatory disclosure with no evident material financial or strategic impact.

• ·Single Item 5.07 filing; mandatory under SEC rules within 4 business days of shareholder meeting (meeting date NOT_DISCLOSED).
• ·Core event: Reporting shareholder vote results (details NOT_DISCLOSED).
• ·No quantitative data (transaction value, shares, percentages, financial metrics: all NOT_DISCLOSED).

17-12-2025

Phillips Edison & Company, Inc. filed a Form 8-K on December 17, 2025, reporting under Item 7.01 for Regulation FD Disclosure. No specific details, transaction values, financial metrics, or content of the disclosure are provided in the filing summary. Analysis is limited to metadata, indicating a voluntary disclosure with unknown materiality.

• ·Single-item filing: Item 7.01 (Regulation FD Disclosure)
• ·Voluntary disclosure; timing compliance unknown due to lack of event details
• ·No quantitative data (e.g., transaction value, shares, financial metrics) disclosed: all NOT_DISCLOSED

17-12-2025

filed SC 14D9/A on December 17, 2025 - Filed: 2025-12-17 AccNo: 0001193125-25-321812 Size: 18 KB

• ·Filing Type: SC 14D9/A
• ·Priority: MEDIUM
• ·Filed: 2025-12-17 AccNo: 0001193125-25-321812 Size: 18 KB

17-12-2025

Two Harbors Investment Corp. filed an 8-K on December 17, 2025, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the event, transaction, or financial metrics are disclosed in the filing summary. Analysis limited to disclosed items; core event NOT_DISCLOSED.

• ·Items reported: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits); multi-item filing.
• ·Voluntary disclosure under generic 'Other Events'; no materiality or quantitative data provided.
• ·Critical information missing: event details, dollar values, financial impacts (all NOT_DISCLOSED).

17-12-2025

Ingersoll Rand Inc. filed a Form 8-K on December 17, 2025, disclosing an officer change under Item 5.02 (Departure/Election of Officers), Regulation FD disclosure under Item 7.01, and exhibits under Item 9.01. No specific details on the officer's position, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Analysis limited to disclosed metadata; critical details NOT_DISCLOSED.

• ·Item 5.02 indicates officer change (appointment, departure, or compensatory arrangement), but key position (e.g., CEO/CFO) and nature NOT_DISCLOSED.
• ·Item 7.01 suggests Regulation FD disclosure, potentially material non-public information shared.
• ·No quantitative data (transaction values, shares, percentages, financial metrics) extracted: all NOT_DISCLOSED.

17-12-2025

SEI Investments Co filed an 8-K on December 17, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment), along with other events (Item 8.01) and exhibits (Item 9.01). Specific details on the officer position, appointment/resignation status, reasons, or quantitative data are NOT_DISCLOSED in the provided summary. This appears to be a standard governance disclosure with no explicit facts on impact.

• ·Officer change reported under Item 5.02
• ·Additional disclosures in Items 8.01 (Other Events) and 9.01 (Exhibits)
• ·Filed timely on 2025-12-17; no names, positions, or reasons specified

17-12-2025

Community West Bancshares filed a multi-item Form 8-K on December 17, 2025, disclosing entry into a material definitive agreement (Item 1.01), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific details on the agreement, transaction value, or financial impacts are provided in the summary. Analysis is limited due to lack of explicit filing content beyond item headers.

• ·Multi-item 8-K: Items 1.01, 7.01, 9.01 reported
• ·Filed same day as event date (2025-12-17); timing compliance unclear without event details
• ·Core event: Entry into material definitive agreement (NOT_DISCLOSED details)

17-12-2025

United Security Bancshares filed a Form 8-K on December 17, 2025, reporting entry into a material definitive agreement (Item 1.01), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific details on the agreement, transaction value, or financial impacts are provided in the summary. Analysis limited to filing structure; full filing review required for substantive assessment.

• ·Multi-item 8-K: Items 1.01, 7.01, 9.01 reported
• ·Core event: Entry into material definitive agreement (details NOT_DISCLOSED)
• ·No quantitative data extracted: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, etc.

17-12-2025

Axil Brands, Inc. filed an 8-K on December 17, 2025, reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific vote outcomes, proposals, or numerical details are disclosed in the provided filing summary. This appears to be a routine mandatory disclosure of shareholder meeting results.

• ·Single-item 8-K filing under Item 5.07 (mandatory for results of shareholder votes).
• ·No transaction values, share counts, financial metrics, or vote specifics disclosed.
• ·Timing compliance and event details (e.g., meeting date) NOT_DISCLOSED.

17-12-2025

Deluxe Corp filed an 8-K on December 17, 2025, reporting Items 1.01 (Entry into Material Definitive Agreement), 2.03 (Creation of Direct Financial Obligation), and 9.01 (Financial Statements and Exhibits). No specific transaction details, dollar values, or financial metrics are disclosed in the provided summary. Analysis is limited to reported items, indicating a material agreement with financial implications.

• ·Multi-item 8-K filing (1.01, 2.03, 9.01); core event is entry into material agreement creating financial obligation.
• ·All quantitative data (transaction value, share count, financial metrics) NOT_DISCLOSED.
• ·Filed same day as event date; compliance with 4-business-day requirement likely but unconfirmed without full filing.

17-12-2025

CNS Pharmaceuticals, Inc. filed a Form 8-K on December 17, 2025, disclosing an event under Item 5.02 related to departure of directors/officers, elections, appointments, or compensatory arrangements. Item 9.01 indicates financial statements and exhibits were filed. No specific details on positions, individuals, reasons, or quantitative data are disclosed.

• ·Item 5.02: Officer/director change or compensatory arrangement
• ·Filed 2025-12-17; AccNo: 0001683168-25-009208
• ·Item 9.01: Exhibits included; no financial metrics or transaction details provided
• ·All quantitative data (transaction value, share count, percentages): NOT_DISCLOSED

17-12-2025

VisionWave Holdings, Inc. filed an 8-K on December 17, 2025, disclosing entry into a material definitive agreement (Item 1.01), completion of acquisition or disposition of assets (Item 2.01), unregistered sales of equity securities (Item 3.02), and financial statements/exhibits (Item 9.01). No specific details on parties, deal structure, valuation, or strategic rationale are disclosed. All quantitative data including transaction value, share count, and financial metrics are NOT_DISCLOSED.

• ·Event involves merger/acquisition completed per Item 2.01.
• ·Unregistered equity sales noted in Item 3.02, potentially tied to deal.
• ·Critical details such as acquirer/target, value, and consideration NOT_DISCLOSED.

17-12-2025

Coursera, Inc. filed a Form 8-K on December 17, 2025, under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). No specific details on the disclosure content, core event, or financial metrics are provided in the filing summary. This is a voluntary multi-item filing with unknown materiality.

• ·Items reported: 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item voluntary disclosure; timing compliance cannot be assessed without event details
• ·No quantitative data (transaction value, shares, percentages, financial metrics) disclosed in summary

17-12-2025

Sagimet Biosciences Inc. filed an 8-K on December 17, 2025, disclosing Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits). No specific details on the core event, transaction value, financial impacts, or quantitative data are provided in the filing summary. Analysis limited to disclosed items; full content review required for materiality assessment.

• ·Items reported: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits); multi-item filing.
• ·Core event and all quantitative data (transaction value, share count, financial metrics): NOT_DISCLOSED.
• ·Voluntary disclosure under Item 8.01; timing compliance within 4 business days: NOT_DISCLOSED.

17-12-2025

Sealed Air Corp/DE filed an 8-K on December 17, 2025, disclosing Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the event, transaction value, or financial metrics are provided in the filing summary. All quantitative data (e.g., transaction value, share count, percentages) is NOT_DISCLOSED.

• ·Items reported: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits); multi-item filing.
• ·Core event details, dollar values, financial impacts, and quantitative metrics NOT_DISCLOSED.
• ·Timing compliance, materiality, and market reaction cannot be assessed due to lack of filing content.

17-12-2025

General Mills Inc filed an 8-K on 2025-12-17 disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits under Item 9.01. No specific financial metrics, transaction values, or quantitative data are mentioned in the provided filing summary. Analysis is limited to filing structure due to lack of detailed content.

• ·Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits) reported; multi-item filing.
• ·Voluntary disclosure typical for Item 2.02 financial results.
• ·No numerical values (e.g., revenue, EPS, transaction size) or guidance changes disclosed in summary.

17-12-2025

PG&E Corp filed a Form 8-K on December 17, 2025, disclosing an officer change under Item 5.02, amendments to articles of incorporation or bylaws under Item 5.03, other events under Item 8.01, and financial statements/exhibits under Item 9.01. Specific details on the officer position, appointment/resignation, reasons, or quantitative data are NOT_DISCLOSED in the provided summary. Analysis is limited to filing items with no factual content on leadership impacts.

• ·Item 5.02: Departure of directors/officers or election/appointment (details NOT_DISCLOSED)
• ·Item 5.03: Amendments to governing documents or fiscal year change (details NOT_DISCLOSED)
• ·Item 8.01: Other events (details NOT_DISCLOSED)
• ·Quantitative data (transaction value, shares, percentages, financial metrics): NOT_DISCLOSED
• ·Critical missing info: Officer name, position (e.g., CEO/CFO), reason for change, board impacts

17-12-2025

Larimar Therapeutics, Inc. filed an 8-K on December 17, 2025, reporting Item 3.02 (Unregistered Sales of Equity Securities), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), and Item 9.01 (Financial Statements and Exhibits). No specific transaction details, values, or financial metrics are disclosed in the provided summary. Analysis is limited to item disclosures, with all quantitative data NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 3.02, 5.03, and 9.01 reported.
• ·Core events involve unregistered equity sales and governance/fiscal changes; no dollar values, share counts, or impacts specified.
• ·Mandatory disclosure under SEC 8-K rules; filing timeliness within 4 business days assumed but not confirmed.

17-12-2025

KULR Technology Group, Inc. filed a Form 8-K on December 17, 2025, under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses material information via Regulation FD with attached exhibits, but no specific event details, financial metrics, or transaction values are provided in the summary. Analysis is limited to filing structure; core content is NOT_DISCLOSED.

• ·Specific Items: 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item voluntary filing under Regulation FD for material non-public information
• ·No quantitative data (e.g., transaction value, share count, financial metrics) extracted: all NOT_DISCLOSED

17-12-2025

ABM Industries Inc filed an 8-K on December 17, 2025, disclosing Items 1.01 (Entry into Material Definitive Agreement), 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific details on the agreement, financial results, or quantitative impacts are provided in the summary. All transaction values, financial metrics, and other key data are NOT_DISCLOSED.

• ·Multi-item 8-K filing covering material agreement entry, financial results, and Reg FD disclosure.
• ·Filed on 2025-12-17; timing compliance with 4-business-day requirement cannot be assessed without event date.
• ·Voluntary elements possible via Item 7.01; core items 1.01 and 2.02 are mandatory for material events.

17-12-2025

Texas Pacific Land Corp filed a Form 8-K on December 17, 2025, under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). No specific details on the disclosure content, events, or financial data are provided in the filing summary. Analysis is limited to filing structure and items reported.

• ·Specific Items: 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item filing: Yes, two items reported
• ·Voluntary disclosure under Regulation FD; exhibits attached

17-12-2025

Flutter Entertainment plc filed an 8-K on December 17, 2025, reporting Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). No details on the core event, transaction, or financial metrics are disclosed in the provided filing summary. Analysis limited to metadata; content not available.

• ·Multi-item 8-K filing: Items 7.01 (voluntary Reg FD) and 9.01 (exhibits).
• ·Timing compliance and event details NOT_DISCLOSED.
• ·No quantitative data (e.g., transaction value, financial metrics) extracted: all NOT_DISCLOSED.

17-12-2025

Skillz Inc. filed an 8-K on December 17, 2025, solely under Item 9.01 for Financial Statements and Exhibits. No core event, transaction details, or quantitative data are disclosed in the provided filing summary. Analysis is severely limited by lack of substantive content.

• ·Single-item 8-K filing: Item 9.01 only (Financial Statements and Exhibits).
• ·No transaction value, financial metrics, or strategic details disclosed (all NOT_DISCLOSED).
• ·Voluntary/mandatory status, timing compliance, and materiality NOT_DISCLOSED.

17-12-2025

filed 8-K/A on December 17, 2025 - Filed: 2025-12-17 AccNo: 0001628280-25-057640 Size: 145 KB Item 3.02: Unregistered Sales of Equity Securities Item 8.01: Other Events Item 9.01:...

• ·Filing Type: 8-K/A
• ·Priority: MEDIUM
• ·Filed: 2025-12-17 AccNo: 0001628280-25-057640 Size: 145 KB Item 3
• ·02: Unregistered Sales of Equity Securities Item 8

17-12-2025

Movano Inc. filed an 8-K on December 17, 2025, disclosing officer changes or elections (Item 5.02), shareholder vote results (Item 5.07), and exhibits (Item 9.01). No specific details on positions affected, reasons, outcomes, or quantitative data are provided in the summary. Analysis is limited to the high-level items triggered, with all key facts NOT_DISCLOSED.

• ·Item 5.02 indicates departure, election, or compensatory arrangements for officers/directors, but specifics NOT_DISCLOSED.
• ·Item 5.07 reports submission of matters to security holder vote, outcomes NOT_DISCLOSED.
• ·No quantitative data (transaction values, shares, percentages, financial metrics) extracted; all NOT_DISCLOSED.

17-12-2025

SharpLink Gaming, Inc. filed an 8-K on December 17, 2025, reporting an officer change (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and exhibits (Item 9.01). No specific details on the officer position, appointment/resignation, reasons, or quantitative data are disclosed in the provided summary. Analysis limited to filing items; critical facts like leadership details are NOT_DISCLOSED.

• ·Item 5.02 discloses departure, election, or appointment of officers/directors
• ·Item 5.03 indicates governance document amendments
• ·Additional items (7.01, 8.01, 9.01) suggest broader material disclosures

17-12-2025

Trulieve Cannabis Corp. filed a Form 8-K on December 17, 2025, reporting under Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. Analysis is limited to filing structure, indicating a material event involving a new agreement and financial obligation.

• ·Multi-item 8-K filing (Items 1.01, 2.03, 8.01, 9.01); mandatory disclosures for material events.
• ·Core event involves entry into material definitive agreement and new financial obligation; details NOT_DISCLOSED.
• ·Filed same day as event date; compliance with 4-business-day window cannot be confirmed without full filing.

17-12-2025

Five9, Inc. filed an 8-K on December 17, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements) and exhibits under Item 9.01. No specific details on the officer, position, reason, or nature of change are provided in the filing summary. Analysis is limited; all quantitative data and key facts are NOT_DISCLOSED.

• ·Item 5.02 filing signals potential leadership transition, but specifics (position, appointment/resignation, reason) NOT_DISCLOSED.
• ·Timely SEC disclosure (within 4 business days requirement met).
• ·No financial metrics, share counts, transaction values, or board impacts mentioned.

17-12-2025

VYNE Therapeutics Inc. filed a multi-item Form 8-K on December 17, 2025, disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), changes in control of the registrant (Item 5.01), departures/elections of directors/officers and compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). These items suggest significant corporate events such as a potential acquisition, merger, or restructuring. No specific transaction details, values, or financial impacts are disclosed in the provided information.

• ·Multi-item 8-K filing covering change of control, material agreements, equity sales, and management changes
• ·Filed same day as event date (Dec 17, 2025), likely within 4-business-day requirement
• ·Core events imply high materiality due to Items 1.01, 5.01, but details NOT_DISCLOSED

17-12-2025

Houston American Energy Corp filed a Form 8-K on December 17, 2025, reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details on votes, outcomes, or numerical data are disclosed in the provided filing summary. This is a single-item, mandatory disclosure likely filed within the required 4 business days post-meeting.

• ·Item 5.07: Routine reporting of shareholder vote submissions
• ·No transaction values, share counts, or financial metrics disclosed
• ·Energy sector company; no sector-wide implications stated

17-12-2025

Moleculin Biotech, Inc. filed a Form 8-K on December 17, 2025, under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). No specific event details, financial data, or transaction information is disclosed in the provided summary. Analysis is limited to filing structure; core content is NOT_DISCLOSED.

• ·Specific Items: 7.01 and 9.01 (multi-item filing)
• ·Regulation FD Disclosure indicates public release of potentially material information
• ·Exhibits attached under Item 9.01; no quantitative data extracted (all NOT_DISCLOSED)

17-12-2025

Trilogy Metals Inc. filed an 8-K on December 17, 2025, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific event details, transaction values, or financial metrics are disclosed in the provided filing summary. Analysis limited to form structure; content requires full filing review.

• ·Items reported: 7.01 (Reg FD Disclosure, voluntary) and 9.01 (exhibits).
• ·Multi-item filing; timing compliance unknown (filed same day as event date).
• ·All quantitative data (transaction value, shares, financial metrics): NOT_DISCLOSED.

17-12-2025

Sutro Biopharma, Inc. filed a Form 8-K on December 17, 2025, under Item 8.01 Other Events. No details on the specific event, transaction, financial impacts, or quantitative data are disclosed in the provided filing summary. Analysis is limited to metadata; core event content is NOT_DISCLOSED.

• ·Specific Item: 8.01 Other Events (single-item filing)
• ·Voluntary disclosure under Item 8.01
• ·No numerical values, transaction details, or financial metrics mentioned (all NOT_DISCLOSED)

17-12-2025

Talen Energy Corp filed Form 8-K on December 17, 2025, under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details of the disclosure, events, or financial data are provided in the filing summary. This indicates voluntary sharing of potentially material information via exhibits.

• ·Items reported: 7.01 (Reg FD Disclosure) and 9.01 (Exhibits)
• ·Multi-item filing; Reg FD suggests material nonpublic info disclosed
• ·All quantitative data (transaction values, shares, metrics): NOT_DISCLOSED

17-12-2025

Toro Co (TORO) filed an 8-K on December 17, 2025, disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, transaction details, or quantitative data are provided in the filing summary. Analysis is limited to filing structure; all key financials are NOT_DISCLOSED.

• ·8-K reports Items 2.02 (Results of Operations) and 9.01 (Financial Statements/Exhibits); multi-item filing.
• ·No revenue, earnings, EPS, transaction values, or percentage changes disclosed.
• ·Timing and compliance details (e.g., 4-business-day window) NOT_DISCLOSED; sector unspecified.

17-12-2025

Jabil Inc filed a Form 8-K on December 17, 2025, disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. This is a multi-item voluntary filing for financial results with no quantitative data or specific metrics provided in the summary. Analysis limited to filing structure due to absence of detailed content.

• ·Items reported: 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item filing; voluntary disclosure of financial results
• ·No transaction values, financial metrics, or quantitative data disclosed

17-12-2025

Spire Global, Inc. filed an 8-K on December 17, 2025, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. No specific financial metrics, transaction values, or quantitative data are disclosed in the provided filing summary. This is a voluntary disclosure of earnings information, limiting detailed analysis.

• ·8-K items reported: 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits); multi-item filing.
• ·Core event: Financial results announcement; all quantitative data (revenue, earnings, transaction values) NOT_DISCLOSED.
• ·Timing and compliance: Filed on 2025-12-17; no details on event timing or 4-business-day compliance.

17-12-2025

Harvard Bioscience Inc filed a Form 8-K on December 17, 2025 (AccNo: 0001171843-25-007972), disclosing multiple material events: entry into a new material definitive agreement (Item 1.01), termination of a prior one (Item 1.02), creation of a direct financial obligation (Item 2.03), and changes in directors/officers or compensatory arrangements (Item 5.02). No specific transaction details, dollar values, or quantitative impacts are disclosed in the provided summary. This multi-item filing indicates significant corporate developments but lacks details for precise assessment.

• ·Multi-item 8-K filing: Items 1.01, 1.02, 2.03, 5.02, 9.01; mandatory disclosure as material events.
• ·Core events involve agreement changes, new financial obligations, and leadership shifts; timing appears compliant (filed same day).
• ·All quantitative data (transaction value, share count, financial metrics) NOT_DISCLOSED; critical details missing from summary.

17-12-2025

Progyny, Inc. filed an 8-K on 2025-12-17 disclosing Item 5.02, indicating departure of directors/officers, election/appointment of directors/officers, or compensatory arrangements. No specifics on positions, individuals, appointment/resignation status, reasons, or quantitative data (e.g., transaction values, share counts) are provided—ALL NOT_DISCLOSED. Analysis limited to filing metadata; neutral signal pending full details.

• ·Item 5.02 event: Officer/director change or compensatory arrangements
• ·Filed 2025-12-17 (AccNo: 0001551306-25-000218); timely SEC compliance
• ·Quantitative data (transaction value, shares, % changes, financial metrics): ALL NOT_DISCLOSED

17-12-2025

ASP Isotopes Inc. filed an 8-K on December 17, 2025, disclosing under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the event, transaction, or exhibits are provided in the filing summary. Analysis is limited due to lack of explicit content.

• ·Items reported: 8.01 (Other Events) and 9.01 (Exhibits); multi-item filing.
• ·Core event: NOT_DISCLOSED; voluntary disclosure under 8.01.
• ·No quantitative data (transaction value, shares, financial metrics): all NOT_DISCLOSED.

17-12-2025

Nutanix, Inc. filed a Form 8-K on December 17, 2025, reporting under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits). No specific details on the events, transactions, or exhibits are disclosed in the provided filing summary. Quantitative data and core event descriptions are NOT_DISCLOSED.

• ·Multi-item 8-K: Items 8.01 and 9.01 only
• ·Voluntary disclosure likely (Item 8.01 is catch-all for other events)
• ·No financial metrics, transaction values, or impacts mentioned

17-12-2025

Treasure Global Inc filed an 8-K on December 17, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). Item 9.01 references financial statements and exhibits. No specific details on positions, individuals, reasons, or quantitative data are provided in the filing summary.

• ·Item 5.02 indicates officer change or compensatory arrangements
• ·Filed 2025-12-17; AccNo: 0001213900-25-122618
• ·Sector not specified; no quantitative data extracted (all NOT_DISCLOSED)

17-12-2025

TIGO ENERGY, INC. filed a Form 8-K on December 17, 2025 (AccNo: 0001213900-25-122558), reporting entry into a Material Definitive Agreement under Item 1.01 and including Financial Statements and Exhibits under Item 9.01. No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. Analysis is limited to filing items, with all quantitative data NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits)
• ·Core event: Entry into undisclosed Material Definitive Agreement
• ·No numerical values (e.g., transaction value, share count) or financial metrics disclosed

17-12-2025

Beneficient filed a Form 8-K on December 17, 2025, reporting Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the disclosure content, core event, or financial metrics are provided in the filing summary. Analysis is limited to metadata, with all quantitative data NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 7.01 (voluntary Reg FD) and 9.01 (exhibits attached).
• ·Timing compliance cannot be assessed without event date; filed within standard 4 business day window presumed but unconfirmed.
• ·Core event, transaction details, and financial impacts NOT_DISCLOSED.

17-12-2025

Udemy, Inc. filed an 8-K on December 17, 2025, disclosing an unspecified event under Item 8.01 (Other Events) with exhibits under Item 9.01. No details on the core event, financial impacts, or quantitative data are provided in the filing summary. Analysis limited to disclosed items only.

• ·Items reported: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item 8-K filing; core event details NOT_DISCLOSED
• ·No quantitative data (transaction value, shares, percentages, metrics: all NOT_DISCLOSED)

17-12-2025

HireQuest, Inc. filed a Form 8-K on December 17, 2025, disclosing under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No core event details, transaction values, or financial metrics are specified in the provided filing summary. Analysis limited to metadata; full content review required for deeper insights.

• ·Specific Items: 7.01 (Regulation FD Disclosure, voluntary) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item filing with attached exhibits
• ·No quantitative data (e.g., transaction values, financial metrics) disclosed in summary

17-12-2025

Nuo Therapeutics, Inc. filed an 8-K on December 17, 2025, reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details on proposals, voting results, or outcomes are disclosed in the provided filing summary. This appears to be a routine, single-item mandatory disclosure with no quantitative data available.

• ·Specific Item reported: 5.07 (Submission of Matters to a Vote of Security Holders)
• ·Single-item filing; no other items mentioned
• ·No transaction values, share counts, percentages, or financial metrics disclosed (all NOT_DISCLOSED)

17-12-2025

Pelthos Therapeutics Inc. filed an 8-K on December 17, 2025, reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details on proposals, votes, or outcomes are provided in the filing summary. This is a routine disclosure of shareholder meeting results.

• ·Specific Item: 5.07 (Submission of Matters to a Vote of Security Holders)
• ·Single-item filing
• ·Filed timely per standard 8-K requirements (within 4 business days)

17-12-2025

MACH NATURAL RESOURCES LP filed an 8-K on December 17, 2025, under Item 5.02 disclosing a change involving departure of directors or certain officers, election or appointment of directors/officers, or compensatory arrangements. No specific names, positions, reasons, or details are provided in the available information. Analysis is constrained by lack of explicit filing content.

• ·Item 5.02 event: Officer or director change or compensatory arrangement
• ·Filed December 17, 2025; AccNo: 0001213900-25-122784
• ·No quantitative data, names, or reasons disclosed

17-12-2025

WRAP TECHNOLOGIES, INC. filed a multi-item Form 8-K on December 17, 2025, disclosing Items 3.03 (material modifications to security holders' rights), 5.02 (director/officer changes), 5.03 (amendments to articles/bylaws), 5.07 (shareholder votes), and 9.01 (exhibits). No specific details, transaction values, or quantitative data provided in summary; core events and impacts NOT_DISCLOSED. Likely mandatory governance-related disclosures warranting full filing review for portfolio implications.

• ·Multi-item 8-K: Items 3.03, 5.02, 5.03, 5.07, 9.01
• ·Focus on governance changes, officer transitions, and shareholder actions
• ·No numerical data (e.g., transaction value, share count: NOT_DISCLOSED)

17-12-2025

Fulton Financial Corp filed an 8-K on December 17, 2025, disclosing Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on positions affected, individuals, reasons, or quantitative data are provided in the available summary. This appears to be a routine disclosure with limited visibility into implications.

• ·Item 5.02 filing: Covers officer/director changes or compensatory arrangements
• ·No details on key positions (e.g., CEO, CFO), appointment/resignation type, or reasons disclosed
• ·No quantitative data (transaction values, share counts, percentages, financial metrics) mentioned: all NOT_DISCLOSED

17-12-2025

Optex Systems Holdings Inc filed an 8-K on December 17, 2025, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction values, or quantitative data are disclosed in the provided filing summary. This appears to be a standard mandatory disclosure for financial results with limited details available for analysis.

• ·Multi-item 8-K filing: Items 2.02 and 9.01 reported
• ·Core event: Disclosure of results of operations and financial condition
• ·No numerical data (e.g., revenue, earnings, transaction values) extracted: all NOT_DISCLOSED

17-12-2025

Blackstone Real Estate Income Trust, Inc. filed an 8-K on December 17, 2025, disclosing unregistered sales of equity securities under Item 3.02. No transaction details, sizes, or financial impacts are provided in the filing summary. This appears to be a single-item, mandatory disclosure with limited visibility into materiality.

• ·Item 3.02: Unregistered Sales of Equity Securities
• ·Filed 2025-12-17 (same-day filing, likely within 4 business hours)
• ·Single-item filing; quantitative data (value, shares) NOT_DISCLOSED

17-12-2025

Transportation & Logistics Systems, Inc. filed an 8-K on December 17, 2025, reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), and changes in directors/officers including compensatory arrangements (Item 5.02), with exhibits (Item 9.01). No specific transaction details, values, or impacts are disclosed in the provided summary. This multi-item filing signals potentially significant corporate developments but requires full filing review due to missing quantitative data.

• ·Multi-item 8-K filing: Items 1.01 (material agreement), 3.02 (unregistered equity sales), 5.02 (director/officer changes), 9.01 (exhibits)
• ·Core events involve material agreement, potential dilution from equity sales, and leadership/compensation updates; all details NOT_DISCLOSED
• ·Timing compliance and specifics NOT_DISCLOSED; factual reporting only from summary

17-12-2025

Flushing Financial Corp filed an 8-K on December 17, 2025, disclosing Other Events under Item 8.01 and Financial Statements/Exhibits under Item 9.01. No specific details on the core event, transaction value, or financial impacts are provided in the filing summary. Analysis limited to disclosed items; all other metrics NOT_DISCLOSED.

• ·Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits) reported; multi-item filing.
• ·Core event details, dollar values, and financial metrics NOT_DISCLOSED.
• ·No quantitative data extracted: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED.

17-12-2025

King Resources, Inc. disclosed an officer change via 8-K filing on December 17, 2025, under Item 5.02 (Departure of Directors/Officers; Election/Appointment; Compensatory Arrangements) and Item 9.01 (Exhibits). No specific details on position, individual, appointment/resignation, or reasons are stated. All quantitative data and key facts NOT_DISCLOSED.

• ·Item 5.02 triggered for unspecified officer/director change or compensation.
• ·Filed timely per SEC 8-K rules (within 4 business days).
• ·Exhibits attached (Item 9.01), but contents NOT_DISCLOSED.

17-12-2025

Akari Therapeutics Plc filed a multi-item 8-K on Dec 17, 2025, reporting entry into (Item 1.01) and termination of (Item 1.02) material definitive agreements, unregistered sales of equity securities (Item 3.02), Reg FD disclosure (Item 7.01), and exhibits (Item 9.01). No specific transaction details, values, or financial impacts disclosed in provided summary. Events suggest significant corporate changes but lack quantification.

• ·Multi-item 8-K filing with Items 1.01, 1.02, 3.02, 7.01, 9.01; mandatory disclosures for material events.
• ·Core events: New/terminated material agreements and unregistered equity sales; timing and filing compliance NOT_DISCLOSED.
• ·Quantitative data (transaction value, share count, financial metrics): NOT_DISCLOSED.

17-12-2025

Scilex Holding Co filed a Form 8-K on 2025-12-17 reporting entry into a material definitive agreement (Item 1.01) and creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), with exhibits (Item 9.01). No specific details on the agreement, transaction value, or financial terms are disclosed in the provided summary. This is a multi-item mandatory filing indicating a potentially significant event.

• ·Items reported: 1.01 (Material Definitive Agreement), 2.03 (Direct Financial Obligation), 9.01 (Exhibits)
• ·Multi-item filing; timing and voluntary/mandatory status per standard 8-K rules (mandatory for these items)
• ·Core event: Entry into material agreement creating financial obligation; all quantitative data (value, shares, metrics) NOT_DISCLOSED

18-12-2025

Starfighters Space, Inc. filed an 8-K on December 18, 2025, reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the disclosure content, events, or financials are provided in the filing summary. Analysis limited to metadata; core event and impacts NOT_DISCLOSED.

• ·Multi-item 8-K: Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits)
• ·Filed December 18, 2025; timing compliance NOT_DISCLOSED
• ·Voluntary disclosure under Reg FD; exhibits attached but content NOT_DISCLOSED

17-12-2025

NVE Corp filed an 8-K on December 17, 2025, reporting Item 1.01: Entry into a Material Definitive Agreement. No details on the agreement's nature, value, or impacts are provided in the summary. Full filing review required for assessment.

• ·Single-item 8-K filing under Item 1.01
• ·Event date aligns with filing date (2025-12-17); timing compliance unknown
• ·All quantitative data (transaction value, shares, financial metrics) NOT_DISCLOSED

17-12-2025

NEONC Technologies Holdings, Inc. filed an 8-K on December 17, 2025, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the disclosed information, events, financials, or exhibits are provided in the filing summary. Analysis is limited to filing structure; core content NOT_DISCLOSED.

• ·Items reported: 7.01 (Regulation FD Disclosure, voluntary) and 9.01 (Financial Statements and Exhibits)
• ·Filing date: December 17, 2025; timing compliance NOT_DISCLOSED
• ·All quantitative data (transaction value, shares, financial metrics): NOT_DISCLOSED

18-12-2025

Vera Therapeutics, Inc. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements). No specific details on the individual, position, appointment/resignation, reasons, or quantitative data provided in the summary. Analysis limited to filing metadata.

• ·Item 5.02 filing indicates unspecified officer or director change.
• ·No names, positions (e.g., CEO/CFO), reasons, or timing details disclosed.
• ·Quantitative data (transaction value, share count, percentages, financial metrics): NOT_DISCLOSED.

17-12-2025

Progressive Corp/OH filed a Form 8-K on December 17, 2025 (AccNo: 0000080661-25-000142), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event details, transaction values, or financial metrics are specified in the filing summary. This is a voluntary multi-item disclosure with all quantitative data NOT_DISCLOSED.

• ·Items reported: 7.01 (Regulation FD Disclosure, voluntary) and 9.01 (Exhibits). Multi-item filing.
• ·Timing: Filed 2025-12-17; compliance with 4-business-day rule cannot be assessed without event date.
• ·No facts on core event, financial impact, or materiality provided beyond item descriptions.

17-12-2025

CF Bankshares Inc. filed an Item 5.02 8-K on December 17, 2025, disclosing an officer change involving departure, election, appointment, or compensatory arrangements, but specific details on position, individual, reason, or terms are NOT_DISCLOSED. No quantitative data or further context provided in the summary. Analysis limited to standard SEC disclosure requirements.

• ·Item 5.02 disclosure for officer/director changes or compensatory arrangements
• ·No details on key position (CEO/CFO/etc.), appointment/resignation, or reasons stated
• ·Filed within SEC 4-business-day window; no board outcomes or financial metrics mentioned

17-12-2025

ASTROTECH Corp filed a multi-item 8-K on December 17, 2025, reporting Item 1.01 (Entry into Material Definitive Agreement), Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.07 (Submission of Matters to a Vote of Security Holders), and Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, transaction value, shareholder vote outcomes, or financial impacts are disclosed in the provided summary. Analysis is limited; all quantitative data (e.g., transaction value, share count) is NOT_DISCLOSED.

• ·Multi-item mandatory 8-K filing; timing appears compliant with Dec 17 event date but business hours unverifiable.
• ·Core event involves material agreement and shareholder rights changes, approved via vote submission.
• ·Exhibits filed but contents NOT_DISCLOSED; flags potential strategic shift.

17-12-2025

Dime Community Bancshares, Inc. filed an 8-K on December 17, 2025, disclosing under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits). No specific details on the event, transaction, or financials are provided in the filing summary. Analysis is limited due to lack of explicit content.

• ·Multi-item 8-K filing: Items 8.01 and 9.01 reported.
• ·Core event under Item 8.01 NOT_DISCLOSED.
• ·No quantitative data (e.g., transaction value, financial metrics) extracted; all NOT_DISCLOSED.

17-12-2025

C & F FINANCIAL CORP filed an 8-K on December 17, 2025, under Item 8.01 Other Events. No details on the core event, financial impacts, or quantitative data are disclosed in the provided filing summary. Analysis is constrained to metadata, indicating a potential voluntary disclosure of unspecified events.

• ·Single-item 8-K filing under Item 8.01 (Other Events)
• ·Filed 2025-12-17; timing compliance and event details NOT_DISCLOSED
• ·No transaction values, financial metrics, or strategic context provided

17-12-2025

Micron Technology Inc filed an 8-K on December 17, 2025, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. This appears to be a routine earnings-related disclosure with limited actionable details available.

• ·Items reported: 2.02 and 9.01 (multi-item filing)
• ·Event: Financial results; core details NOT_DISCLOSED
• ·Quantitative data (revenue, EPS, etc.): NOT_DISCLOSED

17-12-2025

Great Southern Bancorp, Inc. filed an 8-K on December 17, 2025, reporting under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits). No specific details on the event, transaction, or exhibits are disclosed in the provided summary. Quantitative data and material impacts are NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 8.01 and 9.01
• ·Filed: 2025-12-17, AccNo: 0001171843-25-007981
• ·Sector: not specified; no core event details or financial metrics provided

17-12-2025

Winnebago Industries Inc filed an 8-K on 2025-12-17 disclosing matters under Item 5.02 (officer/director changes and compensatory arrangements), Item 5.07 (shareholder votes), and Item 9.01 (exhibits). No specific details on positions affected, reasons for changes, vote outcomes, or quantitative data are provided in the filing summary. Analysis limited to disclosed items; all leadership change facts are NOT_DISCLOSED.

• ·Item 5.02 flags potential officer/departure or appointment, but key details (position, internal/external, reason, timing) NOT_DISCLOSED
• ·Item 5.07 indicates shareholder meeting results, but specifics NOT_DISCLOSED
• ·No quantitative data (transaction values, shares, percentages, financial metrics) extracted: all NOT_DISCLOSED

17-12-2025

Insmed Inc filed an 8-K on December 17, 2025, disclosing Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific core events, transactions, or quantitative data are detailed in the provided filing summary. Analysis limited to item reporting; full content unavailable.

• ·Multi-item 8-K: 7.01 (Reg FD, likely press release), 8.01 (other events), 9.01 (exhibits)
• ·Filed 2025-12-17, AccNo: 0001140361-25-045836, size 220 KB
• ·All quantitative data (transaction value, shares, metrics): NOT_DISCLOSED

17-12-2025

NuScale Power Corp filed a multi-item 8-K on December 17, 2025, reporting amendments to articles of incorporation or bylaws/fiscal year change (Item 5.03), submission of matters to a vote of security holders (Item 5.07), and financial statements/exhibits (Item 9.01). No details on amendment content, vote outcomes, or exhibit specifics are provided in the summary. This appears to be routine post-shareholder meeting disclosure with all quantitative data NOT_DISCLOSED.

• ·Multi-item 8-K: Items 5.03 (governance/fiscal changes), 5.07 (shareholder votes), 9.01 (exhibits)
• ·Mandatory disclosure likely for Item 5.07; timing compliance unknown without event date
• ·No transaction values, share counts, or financial metrics disclosed

17-12-2025

ENERPAC TOOL GROUP CORP filed an 8-K on December 17, 2025, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, transaction values, or quantitative data are mentioned in the provided filing summary. This is a standard financial results announcement with limited details available.

• ·8-K items: 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item filing for financial results
• ·All quantitative data (revenue, EPS, etc.): NOT_DISCLOSED

17-12-2025

Unusual Machines, Inc. filed an 8-K on December 17, 2025, reporting Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No core event details, transaction values, or financial metrics are disclosed in the provided filing summary. Analysis is constrained to filing structure only.

• ·Specific Items: 7.01 (Regulation FD Disclosure, voluntary) and 9.01 (Exhibits).
• ·Multi-item filing; timing and compliance not assessable from summary.
• ·All quantitative data (transaction value, shares, financial metrics): NOT_DISCLOSED.

17-12-2025

Telomir Pharmaceuticals, Inc. filed an 8-K on December 17, 2025, under Item 8.01 Other Events. No specific details on the event, transaction value, or financial impacts are disclosed in the provided filing summary. Analysis limited to metadata; full filing content required for deeper insights.

• ·Single-item 8-K filing under Item 8.01 (Other Events)
• ·Voluntary disclosure category; timing compliance unknown
• ·No quantitative data (e.g., transaction value, share count: NOT_DISCLOSED)

17-12-2025

Neuphoria Therapeutics Inc. filed an 8-K on December 17, 2025, reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No details on specific matters, proposals, or voting outcomes are disclosed. This is a routine disclosure with no quantitative data provided.

• ·Item 5.07: Submission of Matters to a Vote of Security Holders
• ·Filed December 17, 2025; AccNo: 0001213900-25-122777
• ·No transaction values, share counts, or financial metrics mentioned

17-12-2025

SUNation Energy, Inc. filed an 8-K on December 17, 2025, reporting under Item 1.02 the termination of a Material Definitive Agreement. No details on the agreement, transaction value, financial impact, or strategic context are disclosed in the provided summary. This event is material by SEC definition but lacks specificity for deeper assessment.

• ·Item 1.02: Termination of a Material Definitive Agreement
• ·Single-item 8-K filing (Item 1.02 only mentioned)
• ·All quantitative data (transaction value, share count, financial metrics) NOT_DISCLOSED

18-12-2025

Global Net Lease, Inc. filed an 8-K on December 18, 2025, under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). No core event details, transaction values, or financial metrics are disclosed in the provided summary. This is a multi-item voluntary filing with attached exhibits.

• ·Specific Items: 7.01 and 9.01; multi-item filing
• ·Regulation FD Disclosure (Item 7.01) suggests voluntary sharing of material information
• ·No quantitative data (e.g., transaction value, share count: NOT_DISCLOSED)

17-12-2025

Nukkleus Inc. filed an 8-K on December 17, 2025, reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details on matters voted upon, outcomes, or vote tallies are disclosed in the provided filing summary. This is a single-item, mandatory disclosure with no quantitative data available.

• ·Item 5.07 only: Reports shareholder vote submission, single-item filing.
• ·Filed timely (within 4 business days for Item 5.07 per SEC rules).
• ·No transaction values, share counts, or financial metrics disclosed.

17-12-2025

Future FinTech Group Inc. reported the completion of an acquisition or disposition of assets via 8-K filing on 2025-12-17 under Item 2.01, with financial statements and exhibits under Item 9.01. No specific details on parties, structure, valuation, or financial metrics are disclosed in the provided filing summary. Transaction value, share count, and percentage changes are NOT_DISCLOSED.

• ·Item 2.01: Completion of Acquisition or Disposition of Assets - event completed as of filing date
• ·Item 9.01: Financial Statements and Exhibits included, but contents NOT_DISCLOSED here
• ·All quantitative data (transaction value, shares, financial metrics) NOT_DISCLOSED

17-12-2025

Form 8-K filing by MERRILL LYNCH DEPOSITOR INC INDEXPLUS TRUST SERIES 2003-1 on December 17, 2025, reports under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the event, transaction, or exhibits are disclosed in the provided summary. Analysis limited to filing structure; core event content NOT_DISCLOSED.

• ·Specific Items: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits); multi-item filing.
• ·Voluntary disclosure under 8.01; mandatory for 8-K structure.
• ·No quantitative data (transaction value, shares, financial metrics) or event details extracted: all NOT_DISCLOSED.
• ·Company is a trust (likely structured finance); sector not specified.

17-12-2025

Spire Inc filed a Form 8-K on December 17, 2025, reporting under Items 1.01 (Entry into a Material Definitive Agreement) and 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), with exhibits under Item 9.01. No specific details on the agreement, transaction value, or financial terms are disclosed in the provided filing summary. Analysis is limited due to lack of substantive content.

• ·Multi-item 8-K filing: Items 1.01, 2.03, and 9.01.
• ·Core event: Entry into undisclosed material definitive agreement creating a financial obligation.
• ·All quantitative data (transaction value, share count, financial metrics): NOT_DISCLOSED.

17-12-2025

Wheeler Real Estate Investment Trust, Inc. filed an 8-K on December 17, 2025, reporting Item 3.02: Unregistered Sales of Equity Securities. No specific transaction details, values, or share counts are disclosed in the provided filing summary. This appears to be a single-item mandatory disclosure with limited visibility into impact.

• ·Item 3.02 discloses unregistered equity sales, a mandatory 8-K trigger.
• ·No quantitative data (transaction value, share count) provided: NOT_DISCLOSED.
• ·REIT context suggests potential dilution but lacks specifics for assessment.

17-12-2025

BLUSKY AI INC. filed a Form 8-K on December 17, 2025, under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits), Accession No. 0001493152-25-028095, size 218 KB. This is a multi-item filing with no specific event details, transaction values, or financial metrics disclosed in the provided summary. Analysis limited to filing structure; core content of disclosure NOT_DISCLOSED.

• ·Specific Items: 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item 8-K filing; voluntary Reg FD compliance indicated
• ·No quantitative data (e.g., transaction value, share count, financial metrics) extracted: all NOT_DISCLOSED

17-12-2025

Vestand Inc. filed a Form 8-K on December 17, 2025 (AccNo: 0001493152-25-028108), reporting under Item 3.01 a notice of delisting or failure to satisfy continued listing rules, with Item 9.01 for financial statements and exhibits. No specific reasons, values, or impacts are disclosed in the provided summary. This signals removal from US exchange listing.

• ·Items reported: 3.01 (Delisting notice) and 9.01 (Exhibits)
• ·Event: Notice of delisting or listing standard failure
• ·Sector and quantitative details: NOT_DISCLOSED

17-12-2025

Capitol Federal Financial, Inc. filed an 8-K on December 17, 2025, reporting Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific event details, financial metrics, or transaction values are disclosed in the provided summary. Analysis limited to filing structure; core content NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 7.01 and 9.01 only.
• ·Regulation FD disclosure indicates potential material information shared publicly via exhibit.
• ·No quantitative data (e.g., transaction values, financial metrics) extracted; all NOT_DISCLOSED.

17-12-2025

Delta Air Lines, Inc. filed a Form 8-K on December 17, 2025, disclosing an officer change event under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment; Compensatory Arrangements). Item 9.01 references financial statements and exhibits. No specific details on the officer, position, nature of change, or quantitative data are provided in the filing summary.

• ·Item 5.02 indicates officer departure, appointment, election, or compensatory arrangement
• ·Filed within SEC 8-K timeline (within 4 business days)
• ·No names, positions, reasons, or numerical data disclosed

17-12-2025

Parke Bancorp, Inc. filed an 8-K on December 17, 2025, disclosing under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the event, transaction, or exhibits are provided in the summary. Analysis is limited to filing structure with all quantitative data NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 8.01 (voluntary Other Events) and 9.01 (exhibits)
• ·Core event details NOT_DISCLOSED
• ·No financial metrics, transaction values, or impacts specified

17-12-2025

Rain Enhancement Technologies Holdco, Inc. filed an 8-K on December 17, 2025, disclosing amendments to articles of incorporation or bylaws/change in fiscal year under Item 5.03, with exhibits under Item 9.01. No details on the nature of amendments, transaction values, or financial impacts are provided in the filing summary. This is a multi-item governance-related disclosure with no quantitative data disclosed.

• ·Items reported: 5.03 (Amendments to Articles/Bylaws or Fiscal Year Change) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item filing; voluntary/mandatory status and exact timing compliance NOT_DISCLOSED
• ·No dollar values, share counts, or financial metrics mentioned: all NOT_DISCLOSED

17-12-2025

ConnectM Technology Solutions, Inc. filed an 8-K on December 17, 2025, reporting Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the disclosed information, transaction values, or financial impacts are provided in the filing summary. This appears to be a voluntary disclosure of material non-public information with attached exhibits.

• ·Specific Items: 7.01 (Reg FD) and 9.01 (Exhibits) – multi-item filing.
• ·Core event: Regulation FD disclosure (details NOT_DISCLOSED).
• ·Quantitative data: Transaction Value NOT_DISCLOSED; Share Count NOT_DISCLOSED; Percentage Changes NOT_DISCLOSED; Financial Metrics NOT_DISCLOSED.

17-12-2025

THOR INDUSTRIES INC filed an 8-K on December 17, 2025, disclosing Item 5.07: Submission of Matters to a Vote of Security Holders. No specific vote outcomes, numerical data, or further details are provided in the filing summary. This appears to be a routine post-shareholder meeting disclosure.

• ·Specific Item: 5.07 (Submission of Matters to a Vote of Security Holders)
• ·Single-item filing
• ·No quantitative data (e.g., transaction value, share count: NOT_DISCLOSED)

17-12-2025

STRATA Skin Sciences, Inc. filed an 8-K on December 17, 2025, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the core event, transaction, or financial data are disclosed in the filing summary. This is a multi-item filing likely involving voluntary Reg FD disclosure of material non-public information.

• ·Items reported: 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item filing; timing and mandatory/voluntary status not fully assessable without full filing
• ·All quantitative data (transaction value, share count, financial metrics) NOT_DISCLOSED

17-12-2025

Norwood Financial Corp filed a Form 8-K on December 17, 2025, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the events, transactions, or exhibits are disclosed in the provided filing summary. Analysis is limited to metadata, indicating a general voluntary disclosure with unknown materiality.

• ·Specific Items reported: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item filing: Yes (two items)
• ·All quantitative data (transaction value, share count, financial metrics): NOT_DISCLOSED
• ·Core event details: NOT_DISCLOSED

17-12-2025

Azitra, Inc. filed a Form 8-K on December 17, 2025 (AccNo: 0001493152-25-028148), reporting under Item 3.01 (Notice of Delisting or Failure to Satisfy a Continued Listing Rule), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This discloses a delisting event from the US market. No specific details on reasons, financials, or transaction values are provided in the filing summary.

• ·Multi-item 8-K: Items 3.01, 8.01, 9.01
• ·Core event: Notice of delisting or listing rule failure
• ·Mandatory disclosure under SEC rules for delisting notices

18-12-2025

Accenture plc filed an 8-K on December 18, 2025, reporting under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. Analysis is limited to filing structure and lacks substantive content for directional insights.

• ·Multi-item 8-K filing: Items 2.02 and 9.01
• ·Core event: Results of Operations and Financial Condition (details NOT_DISCLOSED)
• ·All quantitative data (revenue, EPS, etc.) NOT_DISCLOSED

17-12-2025

Hyperscale Data, Inc. filed a Form 8-K on December 17, 2025, under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). No core event details, financial metrics, or quantitative data are disclosed in the provided summary. This is a multi-item, likely voluntary filing with limited visibility into content.

• ·Items reported: 7.01 (Reg FD Disclosure) and 9.01 (Exhibits); multi-item filing.
• ·Timing: Filed 2025-12-17; compliance with 4-business-day window cannot be assessed without event date.
• ·All quantitative data (transaction value, shares, financial metrics): NOT_DISCLOSED.

17-12-2025

MillerKnoll, Inc. filed an 8-K on December 17, 2025, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. No specific financial metrics, transaction values, or numerical data are disclosed in the provided filing summary. This is a standard voluntary disclosure of quarterly or periodic financial results.

• ·Items reported: 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item 8-K filing for financial results
• ·Filed via SEC (AccNo: 0000066382-25-000139); timing compliance NOT_DISCLOSED

17-12-2025

8-K filing by Gabelli Dividend & Income Trust on 2025-12-17 discloses Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year) and Item 9.01 (Financial Statements and Exhibits). No dividend details, quantum, dates, or financial metrics explicitly stated in the provided summary. Labeled as 'Dividend' event but filing content indicates governance or fiscal changes, not a dividend declaration.

• ·Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year - specifics NOT_DISCLOSED.
• ·Item 9.01: Financial Statements and Exhibits included - content NOT_DISCLOSED.
• ·No quantitative data (dividend per share, record/ex-date, payout, cash position, etc.) mentioned: all NOT_DISCLOSED.

17-12-2025

iQSTEL Inc filed a Form 8-K on December 17, 2025, under Item 8.01 Other Events. No details on the core event, financial impacts, or quantitative data are explicitly stated in the provided filing summary. Analysis is constrained by lack of substantive content, resulting in neutral investment signal.

• ·Item 8.01: Other Events (single item filing)
• ·Core event and transaction details: NOT_DISCLOSED
• ·All quantitative data (transaction value, share count, financial metrics): NOT_DISCLOSED

17-12-2025

Hudson Technologies Inc. filed a Form 8-K on December 17, 2025, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No details on the core event, transaction, or financials are disclosed in the provided filing summary. This is a multi-item filing with limited visibility into materiality.

• ·Items reported: 8.01 (Other Events), 9.01 (Financial Statements and Exhibits)
• ·Multi-item filing; voluntary disclosure likely (Item 8.01)
• ·All quantitative data (transaction value, shares, metrics) NOT_DISCLOSED

17-12-2025

Marchex Inc filed a Form 8-K on December 17, 2025 (AccNo: 0001193125-25-322769), reporting entry into a material definitive agreement (Item 1.01), departures/elections/appointments of directors/officers and compensatory arrangements (Item 5.02), and submission of matters to a vote of security holders (Item 5.07). This is a multi-item mandatory filing with no specific transaction details, dollar values, or outcomes disclosed in the provided summary. Full filing review required for deeper analysis.

• ·Multi-item 8-K: Items 1.01, 5.02, 5.07 reported
• ·Mandatory disclosures on material agreement, leadership changes, and shareholder votes
• ·No quantitative data (e.g., transaction value, share counts) extracted: all NOT_DISCLOSED

17-12-2025

Hut 8 Corp. filed a Form 8-K on December 17, 2025, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the core event, transaction, or financial metrics are disclosed in the provided filing summary. Analysis is limited to filing structure due to lack of content.

• ·Specific Items: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item filing; voluntary disclosure likely under 8.01
• ·No quantitative data (e.g., transaction value, shares, financial metrics) disclosed: all NOT_DISCLOSED

17-12-2025

CPS Technologies Corp filed an 8-K on December 17, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements). No specific details on position affected, appointment/resignation status, reasons, or quantitative data are provided. Analysis limited to filing summary; critical facts NOT_DISCLOSED.

• ·Item 5.02 disclosure for officer change, filed within SEC 4-business-day requirement.
• ·No details on key position (e.g., CEO/CFO), internal/external hire, or reasons stated.
• ·Quantitative data (transaction value, share count, percentages, financial metrics): NOT_DISCLOSED.

17-12-2025

Cassava Sciences Inc. disclosed an officer change via 8-K filing on December 17, 2025, under Item 5.02 (departures, elections, appointments, or compensatory arrangements of officers/directors) and Item 9.01 (financial statements/exhibits). No specifics on position, individual, appointment/resignation status, reasons, or quantitative data are stated. Analysis limited to filing metadata; all details NOT_DISCLOSED.

• ·Item 5.02 triggered: Officer/director change or compensatory arrangement
• ·No key position (CEO/CFO/etc.), reason, timing, or internal/external status disclosed
• ·Quantitative data (transaction value, shares, percentages, financial metrics): NOT_DISCLOSED

17-12-2025

Splash Beverage Group, Inc. filed an 8-K on 2025-12-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). Item 9.01 references financial statements and exhibits. No specific details on position, individual, reason, or quantitative data are provided in the filing summary.

• ·Item 5.02 indicates officer change event, but key details (position, appointment/resignation, reason) NOT_DISCLOSED
• ·Timely SEC filing (within 4 business days requirement)
• ·No quantitative data extracted: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED

17-12-2025

CITIZENS FINANCIAL SERVICES INC filed an 8-K on 2025-12-17 under Item 8.01 Other Events (AccNo: 0000739421-25-000131, Size: 145 KB). No details on the core event, transaction, or financial impacts are disclosed in the provided filing summary. Analysis severely limited by absence of filing content.

• ·Single item filing: Item 8.01 Other Events.
• ·Voluntary disclosure typical for Item 8.01; timing compliance unknown without event date.
• ·All quantitative data (transaction value, shares, financial metrics) NOT_DISCLOSED.

17-12-2025

Parks America, Inc. filed a Form 8-K on December 17, 2025, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the event, transaction, or exhibits are disclosed in the provided summary. Analysis is limited to filing structure with all quantitative and event specifics marked as NOT_DISCLOSED.

• ·Items reported: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item filing
• ·All transaction values, share counts, percentage changes, and financial metrics: NOT_DISCLOSED
• ·Timing, core event, financial impacts, and market reaction: NOT_DISCLOSED

17-12-2025

Sadot Group Inc. filed a Form 8-K on December 17, 2025, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No details on the specific event, transaction, or exhibits are disclosed in the provided filing summary. This is a multi-item filing with limited transparency on content.

• ·Specific Items: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits)
• ·Core event or transaction details: NOT_DISCLOSED
• ·No numerical data (e.g., transaction value, shares, financial metrics): NOT_DISCLOSED

17-12-2025

Addentax Group Corp. filed an 8-K on December 17, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements). Item 9.01 references financial statements and exhibits. No specific details on the officer, position, reason, or quantitative data are provided in the summary.

• ·Item 5.02 indicates officer change or compensatory arrangement, but key position (e.g., CEO/CFO) NOT_DISCLOSED
• ·Filed within SEC 8-K timeline (4 business days), compliant with disclosure requirements
• ·No board composition, succession details, or financial metrics disclosed

17-12-2025

Lightwave Logic, Inc. filed a Form 8-K on December 17, 2025 (AccNo: 0001079973-25-001867), reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). This multi-item filing signals significant corporate activity, but specific transaction details, values, and impacts are NOT_DISCLOSED. Analysis limited to reported items only.

• ·Multi-item 8-K: Items 1.01, 3.02, 7.01, 9.01; mandatory disclosure for material events.
• ·Core events: Material agreement and unregistered equity sales; no dollar values, share counts, or financial metrics disclosed.
• ·All quantitative data (transaction value, share count, percentages, financial metrics): NOT_DISCLOSED.

17-12-2025

U.S. GoldMining Inc. filed an 8-K on December 17, 2025 (AccNo: 0001493152-25-028151), disclosing Item 5.02 related to departure of directors/officers, election/appointment of directors/officers, or compensatory arrangements. No specific details on positions, individuals, reasons, or quantitative data are provided in the filing summary. Analysis is limited due to lack of explicit content.

• ·Item 5.02 filing indicates officer or director change event
• ·Filed within SEC 4-business-day requirement
• ·No quantitative data (e.g., shares, values, percentages) disclosed: NOT_DISCLOSED

17-12-2025

BRT Apartments Corp. filed an 8-K on December 17, 2025, disclosing under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the core event, transaction value, or financial impacts are provided in the filing summary. Analysis is severely limited by lack of explicit content.

• ·Items reported: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits); multi-item filing.
• ·Core event and all quantitative data (e.g., transaction value, share count) NOT_DISCLOSED.
• ·Voluntary disclosure likely under Item 8.01; timing compliance unknown without event details.

17-12-2025

N-able, Inc. filed a Form 8-K on December 17, 2025, under Item 5.02 disclosing an officer change, director election, appointment, or compensatory arrangement. No specific details on positions affected, appointment/resignation status, reasons, or quantitative data are provided in the summary. Analysis is limited; all key facts such as leadership role, timing, and impacts are NOT_DISCLOSED.

• ·Item 5.02 filing signals potential officer departure, appointment, or compensation update.
• ·No details on key position (e.g., CEO/CFO), internal/external hire, reasons, or board impacts disclosed.
• ·Quantitative data (transaction values, shares, percentages, financial metrics) all NOT_DISCLOSED.

17-12-2025

Wolfspeed, Inc. filed an 8-K on December 17, 2025, disclosing Item 5.07 (Submission of Matters to a Vote of Security Holders) and Item 9.01 (Financial Statements and Exhibits). No specific details on vote outcomes, proposals, or exhibits are provided. This appears to be a standard post-shareholder meeting disclosure.

• ·Multi-item 8-K filing: Items 5.07 and 9.01
• ·Reports results of security holder votes; exhibits attached
• ·No quantitative data, transaction values, or financial metrics disclosed

17-12-2025

CNX Resources Corp filed a multi-item Form 8-K on December 17, 2025, reporting unregistered sales of equity securities (Item 3.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific details on transaction values, sizes, or impacts are disclosed in the provided summary. Analysis is limited to item descriptions; full filing review needed for materiality assessment.

• ·Multi-item 8-K: Items 3.02 (Unregistered Sales of Equity Securities), 8.01 (Other Events), 9.01 (Exhibits)
• ·Core event: Unregistered equity sales and unspecified other events; all quantitative data NOT_DISCLOSED
• ·Compliance timing and details NOT_DISCLOSED; mandatory for Item 3.02

17-12-2025

Star Gold Corp. filed an 8-K on December 17, 2025, solely under Item 9.01 for Financial Statements and Exhibits. No details on the specific exhibits, events, or financial data are provided in the filing summary. Analysis limited to disclosed information; full filing review required for deeper insights.

• ·Single-item 8-K filing under Item 9.01 (Financial Statements and Exhibits)
• ·No quantitative data (e.g., transaction values, shares, financial metrics) disclosed
• ·Sector not specified; general filing with AccNo 0001437749-25-038183

17-12-2025

Vistra Corp. filed a Form 8-K on December 17, 2025, reporting solely under Item 8.01 Other Events. No specific details on the event, transaction value, financial impacts, or strategic implications are disclosed in the provided summary. Analysis is limited to filing metadata; all quantitative and event-specific data is NOT_DISCLOSED.

• ·Single-item 8-K filing under Item 8.01 (Other Events)
• ·Filed 2025-12-17 (AccNo: 0001193125-25-322976); timing compliance unknown without event date
• ·Voluntary disclosure typical for Item 8.01; core event NOT_DISCLOSED

18-12-2025

FactSet Research Systems Inc filed an 8-K on December 18, 2025, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. This appears to be a standard earnings-related disclosure with exhibits likely attached.

• ·Specific Items: 2.02 and 9.01 reported in multi-item 8-K filing
• ·Core event: Results of Operations and Financial Condition
• ·Quantitative data (revenue, EPS, etc.): NOT_DISCLOSED

17-12-2025

CareTrust REIT, Inc. filed a Form 8-K on December 17, 2025, reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. Analysis limited to filing structure; full content required for substantive assessment.

• ·Multi-item 8-K filing: Items 1.01, 8.01, 9.01
• ·Core event: Entry into Material Definitive Agreement (details NOT_DISCLOSED)
• ·All quantitative data (transaction value, shares, metrics) NOT_DISCLOSED

17-12-2025

Gloo Holdings, Inc. filed a Form 8-K on December 17, 2025, disclosing results of operations and financial condition (Item 2.02), unregistered sales of equity securities (Item 3.02), and financial statements/exhibits (Item 9.01). No specific financial metrics, transaction values, or details are provided in the filing summary. This multi-item filing signals operational updates and potential dilution but lacks quantification.

• ·Specific Items: 2.02 (Results of Operations), 3.02 (Unregistered Equity Sales), 9.01 (Financial Statements/Exhibits); multi-item filing.
• ·All quantitative data (transaction value, share count, financial metrics) NOT_DISCLOSED.
• ·Mandatory disclosure triggered by events; timing compliance cannot be assessed without event date.

17-12-2025

RAYMOND JAMES FINANCIAL INC filed an 8-K on December 17, 2025, reporting Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the disclosure content, core event, financial metrics, or exhibits are provided in the filing summary. Quantitative data such as transaction values, share counts, or percentage changes are NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 7.01 (Reg FD Disclosure, voluntary) and 9.01 (Financial Statements/Exhibits).
• ·Core event details NOT_DISCLOSED; timing compliance with 4-business-day rule cannot be assessed without event date.
• ·No revenue, earnings, balance sheet impacts, or guidance changes mentioned.

17-12-2025

Ondas Holdings Inc. filed a Form 8-K on December 17, 2025, disclosing entry into a material definitive agreement (Item 1.01), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific details on the agreement terms, transaction value, or financial impacts are provided in the summary. This multi-item filing signals a potentially significant event but lacks quantitative data.

• ·Reported Items: 1.01 (Material Definitive Agreement), 7.01 (Regulation FD Disclosure), 9.01 (Financial Statements and Exhibits)
• ·Multi-item mandatory/voluntary filing (1.01 mandatory, 7.01 voluntary)
• ·Filed same day as event date; timing compliance NOT_DISCLOSED

17-12-2025

Solo Brands, Inc. filed a Form 8-K on December 17, 2025, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided filing summary. Analysis is constrained by lack of substantive content from the filing.

• ·8-K Items: 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item filing; core event is unspecified material definitive agreement
• ·All quantitative data (transaction value, shares, financial metrics) NOT_DISCLOSED

17-12-2025

CIMG Inc. filed an 8-K on December 17, 2025, disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), with Regulation FD disclosure (Item 7.01) and financial exhibits (Item 9.01). No specific details on parties, deal structure, valuation, or financial metrics are provided in the filing summary. Analysis is limited to disclosed items; all quantitative data (transaction value, share count, etc.) is NOT_DISCLOSED.

• ·Event: Completed merger/acquisition announced via Items 1.01 and 2.01.
• ·No parties, valuation, consideration type, or synergies explicitly stated.
• ·Financial statements/exhibits referenced in Item 9.01 but content NOT_DISCLOSED.

17-12-2025

AIM ImmunoTech Inc. filed a Form 8-K on December 17, 2025, reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details on proposals, vote outcomes, or quantitative data are disclosed in the provided filing summary. This appears to be a routine, single-item mandatory disclosure.

• ·Specific Item: 5.07 (Submission of Matters to a Vote of Security Holders)
• ·Single-item filing; timing and compliance not detailed beyond filing date
• ·No transaction values, share counts, financial metrics, or vote results disclosed (all NOT_DISCLOSED)

17-12-2025

Seaport Entertainment Group Inc. filed an 8-K on December 17, 2025, disclosing entry into a Material Definitive Agreement under Item 1.01, with exhibits under Item 9.01. No specific details, transaction values, or financial impacts are provided in the filing summary. Analysis is limited to filing structure; all quantitative data is NOT_DISCLOSED.

• ·Items reported: 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits); multi-item filing.
• ·Core event: Entry into unspecified Material Definitive Agreement; strategic importance and financial impacts NOT_DISCLOSED.
• ·No numerical data extracted: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED.

17-12-2025

Immunome Inc. filed an 8-K on December 17, 2025, reporting 'Other Events' under Item 8.01 and attaching financial statements/exhibits under Item 9.01. No specific details on the events, transactions, or financial metrics are disclosed in the provided filing summary. Analysis is limited to filing structure without content specifics.

• ·Items reported: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item filing; voluntary disclosure typical for 8.01
• ·No quantitative data (e.g., transaction values, shares) disclosed: NOT_DISCLOSED

17-12-2025

Customers Bancorp, Inc. filed an 8-K on December 17, 2025, disclosing entry into a Material Definitive Agreement under Item 1.01, with exhibits under Item 9.01. No specific details on the agreement's terms, value, or parties are provided in the summary. Quantitative data and financial impacts are NOT_DISCLOSED, limiting assessment.

• ·Items reported: 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits); multi-item filing.
• ·Core event: Entry into undisclosed material agreement; all transaction values, shares, percentages NOT_DISCLOSED.
• ·Timing, financial impacts, regulatory details, market reactions NOT_DISCLOSED in provided information.

17-12-2025

Cisco Systems, Inc. filed an 8-K on December 17, 2025, disclosing matters under Item 5.02 (officer/director changes or compensatory arrangements), Item 5.07 (shareholder vote results), and Item 9.01 (exhibits). No specific details on officers, positions, reasons, votes, or quantitative data provided in the summary. Event appears informational with no disclosed material impacts.

• ·Item 5.02 triggered: Indicates officer departure, election, appointment, or compensatory arrangements (details NOT_DISCLOSED).
• ·Item 5.07 triggered: Shareholder matters submitted to vote (outcomes NOT_DISCLOSED).
• ·No quantitative data (e.g., transaction values, shares, percentages) extracted: ALL NOT_DISCLOSED.
• ·Critical missing info: Officer names, positions (e.g., CEO/CFO), appointment/resignation type, reasons, vote results.

17-12-2025

UWM Holdings Corp filed an 8-K on December 17, 2025, reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific event details, transaction values, or financial metrics are disclosed in the provided filing summary. Analysis is limited to filing structure; core content NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 7.01, 8.01, 9.01
• ·Item 7.01 indicates Regulation FD voluntary disclosure; 8.01 for other events (materiality uncertain)
• ·No quantitative data (e.g., transaction value, shares, financial metrics) extracted: all NOT_DISCLOSED

17-12-2025

Franklin Resources Inc filed an 8-K on December 17, 2025, disclosing Item 1.01 (Entry into Material Definitive Agreement), Item 2.03 (Creation of Direct Financial Obligation), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific transaction details, dollar values, or financial metrics are provided in the summary. Analysis limited to filing structure; core event details NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 1.01, 2.03, 8.01, 9.01 reported.
• ·Suggests material agreement and new financial obligation, but transaction specifics NOT_DISCLOSED.
• ·Quantitative data (value, shares, metrics) all NOT_DISCLOSED.

17-12-2025

AI Technology Group Inc. filed an 8-K on 2025-12-17 announcing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), with unregistered equity sales (Item 3.02). No details on parties, structure, valuation, or rationale provided in the summary. All quantitative data and specifics are NOT_DISCLOSED.

• ·Event: Merger/Acquisition completed per Items 1.01 and 2.01
• ·Involves unregistered equity securities (Item 3.02), suggesting stock consideration
• ·Financial statements/exhibits in Item 9.01; critical details like deal value, parties NOT_DISCLOSED

17-12-2025

Celanese Corp filed an 8-K on December 17, 2025, reporting entry into a material definitive agreement (Item 1.01) and creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), with exhibits (Item 9.01). No specific details on the transaction, value, or terms are disclosed in the provided summary. Analysis is limited to item disclosures; all quantitative data is NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 1.01, 2.03, and 9.01.
• ·Core event involves a material definitive agreement creating a financial obligation.
• ·No transaction value, share count, percentage changes, or financial metrics disclosed.

17-12-2025

Xcel Energy Inc filed an 8-K on December 17, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). No specific details on the officer's position, nature of change (appointment/resignation), reasons, or quantitative data are disclosed in the provided summary. Analysis limited to filing metadata.

• ·Item 5.02 filing indicates officer-related event (departure, election, appointment, or compensatory arrangement).
• ·Filed within SEC 8-K requirements (within 4 business days); AccNo: 0000072903-25-000273.
• ·No names, positions, reasons, or financial metrics explicitly stated - all marked NOT_DISCLOSED.

17-12-2025

BioMarin Pharmaceutical Inc. disclosed an Item 5.02 event on December 17, 2025, regarding departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on individuals, positions, reasons, or quantitative data are provided in the filing summary. This is a standard SEC 8-K disclosure with limited information available for analysis.

• ·Item 5.02 filing on officer/director changes or compensatory arrangements
• ·Filed December 17, 2025; AccNo: 0001193125-25-322704
• ·No names, positions, reasons, or numerical data explicitly stated

17-12-2025

Horizon Technology Finance Corp filed an 8-K on December 17, 2025, disclosing entry into a Material Definitive Agreement under Item 1.01, with exhibits under Item 9.01. No specific details on the agreement's terms, value, or parties are provided in the summary. Analysis is limited due to lack of filing content beyond item descriptions.

• ·8-K reports Items 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits); multi-item filing.
• ·Core event is entry into a material definitive agreement; all transaction details (value, size, strategic role) NOT_DISCLOSED.
• ·No quantitative data extracted: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED.

17-12-2025

Fastly, Inc. filed a Form 8-K on December 17, 2025, reporting Items 1.01 (Entry into Material Definitive Agreement), 2.03 (Creation of Direct Financial Obligation), 3.02 (Unregistered Sales of Equity Securities), and 8.01 (Other Events). No specific transaction details, dollar values, share counts, or financial metrics are disclosed in the provided summary. Analysis is limited to reported items; all quantitative data is NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 1.01, 2.03, 3.02, 8.01.
• ·Core events involve material agreement, financial obligation, and unregistered equity sales; details NOT_DISCLOSED.
• ·Timing compliance, financial impacts, and market reactions cannot be assessed without filing content.

17-12-2025

Insulet Corp filed a Form 8-K on December 17, 2025, disclosing an event under Item 5.02 related to departure of directors/officers, election/appointment of directors/officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions, individuals, reasons, or quantitative data are disclosed in the provided filing summary.

• ·Item 5.02: Covers officer/director departures, elections, appointments, or compensatory arrangements - specifics NOT_DISCLOSED
• ·Item 9.01: Financial statements and exhibits filed
• ·Event filed within SEC 8-K timeline (Dec 17, 2025); no quantitative data (e.g., share counts, values) mentioned

17-12-2025

UNITED NATURAL FOODS INC filed an 8-K on 2025-12-17 disclosing an officer or director change (Item 5.02), submission of matters to shareholder vote (Item 5.07), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific details on positions, reasons, or individuals affected are provided. Quantitative data such as transaction values, share counts, or financial metrics are NOT_DISCLOSED.

• ·Item 5.02 indicates departure, election, or appointment of directors/officers, but key position, type (appointment/resignation), reason, and timing NOT_DISCLOSED
• ·Item 5.07 reports shareholder vote outcomes, details NOT_DISCLOSED
• ·Items 8.01 and 9.01 cover other events and exhibits, specifics NOT_DISCLOSED

17-12-2025

Zevra Therapeutics, Inc. filed a Form 8-K on December 17, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer, position, appointment/resignation status, reasons, or quantitative data are disclosed in the provided filing summary. Analysis is limited to factual disclosure of the event type without substantive content.

• ·Item 5.02 indicates an officer change event (departure, election, appointment, or compensatory arrangements)
• ·Item 9.01 lists financial statements and exhibits (details NOT_DISCLOSED)
• ·No names, positions, reasons, timing, or quantitative metrics (e.g., transaction value, share count) mentioned

17-12-2025

Stabilis Solutions, Inc. filed an 8-K on December 17, 2025, reporting entry into a Material Definitive Agreement under Item 1.01, with exhibits under Item 9.01. No details on the agreement terms, transaction value, or financial impacts are disclosed in the provided summary. Analysis is limited to filing items, indicating a material event but lacking specifics for directional assessment.

• ·Multi-item 8-K filing: Items 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits)
• ·Core event: Entry into undisclosed material definitive agreement
• ·All quantitative data (transaction value, shares, financial metrics) NOT_DISCLOSED

17-12-2025

Healthcare Realty Trust Inc filed an 8-K on December 17, 2025, disclosing entry into a Material Definitive Agreement under Item 1.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the agreement, transaction value, or financial impacts are provided in the summary. Analysis is limited; full filing review required for materiality assessment.

• ·8-K reports Items 1.01 (Entry into Material Definitive Agreement) and 9.01 (Exhibits); multi-item filing.
• ·Core event: Entry into material agreement, but terms, value, and impacts NOT_DISCLOSED.
• ·No quantitative data (transaction value, shares, metrics) extracted; all NOT_DISCLOSED.

17-12-2025

Tompkins Financial Corp filed an 8-K on December 17, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements). No specific details on the officer's name, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or quantitative data are provided. This is a routine SEC disclosure with limited information available.

• ·Item 5.02 filing for officer change or compensatory arrangements
• ·Filed 2025-12-17 (AccNo: 0001999371-25-020552)
• ·No names, positions, reasons, or financial metrics disclosed

17-12-2025

Sylvamo Corp filed an 8-K on December 17, 2025, disclosing an officer change under Item 5.02 (Departure/Election of Officers or Compensatory Arrangements), Regulation FD disclosure under Item 7.01, and exhibits under Item 9.01. No specific details on positions, reasons, or individuals are provided in the summary. Analysis limited to filing structure; full content NOT_DISCLOSED.

• ·Item 5.02 indicates officer departure, election, appointment, or compensatory arrangements - specifics NOT_DISCLOSED
• ·Item 7.01: Regulation FD Disclosure - material non-public information shared, details NOT_DISCLOSED
• ·Item 9.01: Financial Statements and Exhibits filed, content NOT_DISCLOSED

17-12-2025

FOCUS UNIVERSAL INC. filed an 8-K on December 17, 2025, reporting under Item 8.01 Other Events. No specific details on the event, transaction, or financial impacts are disclosed in the provided filing summary. Analysis limited to metadata; core content unavailable.

• ·Single-item 8-K filing under Item 8.01 (Other Events)
• ·Voluntary disclosure; timing compliance cannot be assessed without event date
• ·All quantitative data (transaction value, shares, financial metrics) NOT_DISCLOSED

17-12-2025

Pioneer Bancorp, Inc./MD filed a Form 8-K on December 17, 2025, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the core event, transaction value, financial impacts, or quantitative data are disclosed in the filing summary. This is a multi-item, general filing with unknown materiality.

• ·Specific Items: 8.01 and 9.01 only; multi-item filing.
• ·No core event details, dollar values, or financial metrics disclosed (all NOT_DISCLOSED).
• ·Voluntary disclosure under Item 8.01; compliance with 8-K timing cannot be assessed without event date.

17-12-2025

Concord Acquisition Corp II filed an 8-K on December 17, 2025, reporting amendments to articles of incorporation or bylaws (Item 5.03), submission of matters to a vote of security holders (Item 5.07), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific merger/acquisition details, parties, valuation, or quantitative data are disclosed in the provided filing summary. Analysis limited to filing metadata indicating potential SPAC-related governance changes and shareholder approval.

• ·8-K items suggest shareholder vote and governance amendments, common in SPAC de-SPAC mergers.
• ·No transaction value, parties, structure, or financial metrics disclosed.
• ·Sector not specified; critical deal details missing.

17-12-2025

Essential Properties Realty Trust, Inc. filed an 8-K on December 17, 2025, reporting an officer change under Item 5.02 (Departure/Election/Appointment of Officers/Directors or Compensatory Arrangements), with Regulation FD disclosure (Item 7.01) and exhibits (Item 9.01). No specific details on positions affected, appointment/resignation status, reasons, or quantitative data are disclosed in the provided filing summary. Analysis limited to metadata; critical facts like names, roles, and impacts are NOT_DISCLOSED.

• ·Item 5.02 covers officer/director departures, elections, appointments, or compensatory arrangements - routine SEC disclosure.
• ·Filed on 2025-12-17 via AccNo 0001728951-25-000188, compliant with 4-business-day 8-K requirement.
• ·No quantitative data (e.g., transaction values, share counts, percentages) or board outcomes mentioned; all NOT_DISCLOSED.

17-12-2025

Shore Bancshares Inc disclosed an officer change via Form 8-K filed on December 17, 2025, under Item 5.02 (Departure/Election/Appointment of Officers/Directors; Compensatory Arrangements) and Item 9.01 (Exhibits). No specific details on position, individual, reason, or quantitative data are provided in the summary.

• ·Item 5.02 covers officer/director changes or compensatory arrangements
• ·Item 9.01 lists financial statements and exhibits
• ·All specifics (names, roles, reasons, numbers) NOT_DISCLOSED

17-12-2025

Bausch & Lomb Corp filed a Form 8-K on December 17, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment). No specific details on the position affected, nature of change (appointment/resignation), reasons, or quantitative data are provided in the filing summary. Item 9.01 references financial statements/exhibits, but contents are NOT_DISCLOSED.

• ·Event involves officer change per Item 5.02, filed timely on 2025-12-17.
• ·No names, positions (e.g., CEO/CFO), reasons, or succession details disclosed.
• ·Quantitative data (transaction values, shares, percentages) all NOT_DISCLOSED.

17-12-2025

Ardeylix, Inc. filed an 8-K on December 17, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment), with additional Items 8.01 (Other Events) and 9.01 (Exhibits). No specific details on the officer, position (e.g., CEO/CFO), reason, or quantitative data are provided in the summary. Analysis is limited; all key facts such as names, roles, and impacts are NOT_DISCLOSED.

• ·Item 5.02 filing signals officer departure, election, or appointment, but position, internal/external status, and reason NOT_DISCLOSED.
• ·No quantitative data extracted: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED.
• ·Compliance with SEC 8-K timing met (filed same day); governance/stock impact indeterminable without details.

17-12-2025

Heritage Commerce Corp filed an 8-K on December 17, 2025, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No details on the specific event, transaction, financial metrics, or exhibits are disclosed in the provided filing summary. This is a multi-item, likely mandatory disclosure with limited transparency on content.

• ·Items reported: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits); multi-item filing
• ·Core event: NOT_DISCLOSED
• ·Quantitative data (transaction value, shares, percentages, financial metrics): all NOT_DISCLOSED

17-12-2025

Banzai International, Inc. filed a Form 8-K on December 17, 2025, reporting Items 1.01 (Entry into Material Definitive Agreement), 2.03 (Creation of Direct Financial Obligation), 3.02 (Unregistered Sales of Equity Securities), 5.03 (Amendments to Articles of Incorporation or Bylaws), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific transaction details, dollar values, or quantitative data disclosed in the provided summary. Analysis limited to item descriptions; all other metrics NOT_DISCLOSED.

• ·Multi-item 8-K filing (Items 1.01, 2.03, 3.02, 5.03, 9.01); mandatory disclosures triggered by events.
• ·Core events involve material agreement, new financial obligation, equity sales, and governance changes; timely filing (same day as event date).
• ·No numerical data extracted: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED.

17-12-2025

AAR CORP filed an 8-K on December 17, 2025, reporting Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific event details, financial metrics, or transaction data provided in the filing summary.

• ·Multi-item 8-K filing: Items 7.01, 8.01, 9.01
• ·Regulation FD suggests voluntary disclosure; 8.01 indicates other events
• ·Exhibits likely attached but content NOT_DISCLOSED

17-12-2025

Stardust Power Inc. filed an 8-K on December 17, 2025, reporting the termination of a material definitive agreement under Item 1.02, with exhibits under Item 9.01. No details on the agreement, transaction value, or financial impacts are disclosed. This signals a potentially negative event, but lacks specifics for full assessment.

• ·8-K items: 1.02 (Termination of Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits)
• ·Core event: Termination of a material definitive agreement; multi-item filing
• ·No quantitative data (e.g., dollar value, share count) disclosed

17-12-2025

22nd Century Group, Inc. filed a Form 8-K on 2025-12-17 disclosing Items 1.01 (Entry into Material Definitive Agreement), 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws), and 9.01 (Financial Statements and Exhibits). This multi-item filing signals significant corporate governance and transactional changes, but specific details are NOT_DISCLOSED. Compliance with 4-business-day filing appears met based on date.

• ·Multi-item mandatory 8-K: Items 1.01, 3.03, 5.03, 9.01
• ·Core events involve material agreement, shareholder rights modifications, and governance amendments
• ·No quantitative data (e.g., transaction value, share count) disclosed in summary

17-12-2025

Meshflow Acquisition Corp filed an 8-K on December 17, 2025 (AccNo: 0001213900-25-122857), disclosing a merger/acquisition under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific deal structure, parties, valuation, or quantitative details are explicitly stated in the provided filing summary. Sector is not specified.

• ·Item 8.01: Other Events related to merger/acquisition
• ·Item 9.01: Financial Statements and Exhibits included
• ·All transaction specifics (value, parties, terms) NOT_DISCLOSED

17-12-2025

Natural Alternatives International Inc. filed a Form 8-K on December 17, 2025 (AccNo: 0001437749-25-038181), reporting entry into a material definitive agreement under Item 1.01 and financial statements/exhibits under Item 9.01. No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. This is a multi-item mandatory filing with limited public information available.

• ·Items reported: 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits)
• ·Filing date: 2025-12-17; multi-item 8-K
• ·All quantitative data (transaction value, share count, financial metrics): NOT_DISCLOSED

17-12-2025

Inspire Veterinary Partners, Inc. filed an 8-K on December 17, 2025, reporting entry into a material definitive agreement under Item 1.01 and attaching financial statements and exhibits under Item 9.01. No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. This represents a mandatory disclosure of a potentially significant event.

• ·Items reported: 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits).
• ·Multi-item filing; core event is entry into a material agreement.
• ·All quantitative data (transaction value, share count, financial metrics) NOT_DISCLOSED.

17-12-2025

Sable Offshore Corp. filed an 8-K on December 17, 2025, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the core event, transaction values, or financial impacts are disclosed in the provided summary. This appears to be a voluntary multi-item filing with limited visibility into content.

• ·Items reported: 7.01 (Regulation FD Disclosure, voluntary) and 9.01 (Exhibits).
• ·Multi-item filing; timing compliance NOT_DISCLOSED.
• ·All quantitative data (transaction value, shares, financial metrics) NOT_DISCLOSED.

17-12-2025

RYVYL Inc. filed an 8-K on December 17, 2025, reporting Items 5.07 (Submission of Matters to a Vote of Security Holders), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on vote outcomes, events, or exhibits are disclosed in the provided summary. Analysis is limited to item disclosures; all transaction values, financial metrics, and quantitative data are NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 5.07, 8.01, and 9.01.
• ·Core events include shareholder vote submission and unspecified 'Other Events'; no dollar values or details provided.
• ·Compliance with 8-K filing appears timely based on date, but specifics NOT_DISCLOSED.

17-12-2025

USBC, Inc. filed an 8-K on 2025-12-17 disclosing officer/director changes (Item 5.02), bylaws amendments or fiscal year change (Item 5.03), and exhibits (Item 9.01). No specific details on positions affected, appointment/resignation status, reasons, or quantitative data are provided. Analysis limited to filing items triggered; critical facts NOT_DISCLOSED.

• ·Item 5.02: Departure/election/appointment of directors/officers or compensatory arrangements
• ·Item 5.03: Amendments to articles/bylaws or fiscal year change
• ·Item 9.01: Financial statements/exhibits filed; no numerical values or specifics extracted (ALL NOT_DISCLOSED)

17-12-2025

Commercial Metals Co filed a Form 8-K on December 17, 2025, reporting entry into a material definitive agreement (Item 1.01) that creates a direct financial obligation (Item 2.03), with Regulation FD disclosure (Item 7.01) and exhibits (Item 9.01). No specific transaction details, values, or financial metrics are disclosed in the provided summary. Analysis is limited to item descriptions; all quantitative data is NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 1.01 (Material Definitive Agreement), 2.03 (Financial Obligation), 7.01 (Reg FD), 9.01 (Exhibits).
• ·Core event involves a material agreement creating financial obligation; strategic or financial impact unknown.
• ·Filing timing, compliance, and market reaction indicators NOT_DISCLOSED.

17-12-2025

Kalaris Therapeutics, Inc. filed an 8-K on December 17, 2025, under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific event details, transaction values, or financial metrics are disclosed in the provided filing summary. Analysis is limited to item disclosures, indicating voluntary material information sharing and attached exhibits.

• ·Multi-item 8-K filing (7.01, 8.01, 9.01)
• ·Item 7.01 suggests Regulation FD compliance for material nonpublic info
• ·Item 8.01 reports unspecified other events; exhibits in 9.01

17-12-2025

NNN REIT, INC. filed a Form 8-K on December 17, 2025, reporting under Items 1.01 (Entry into a Material Definitive Agreement) and 2.03 (Creation of a Direct Financial Obligation). No specific details on the agreement, transaction value, or financial terms are disclosed in the provided filing summary. This is a multi-item mandatory disclosure of a material event.

• ·Items reported: 1.01 and 2.03 (multi-item filing)
• ·Core event: Entry into material definitive agreement creating direct financial obligation (exact nature NOT_DISCLOSED)
• ·Quantitative data (transaction value, share count, financial metrics): all NOT_DISCLOSED

17-12-2025

New Fortress Energy Inc. filed a Form 8-K on December 17, 2025, reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 financial statements and exhibits. No specific details, transaction values, or financial impacts are disclosed in the provided summary. Analysis is limited to these items, with all other data NOT_DISCLOSED.

• ·Items reported: 1.01 (Material Definitive Agreement) and 9.01 (Exhibits)
• ·Multi-item 8-K filing; core event is entry into unnamed material agreement
• ·Timing and compliance details NOT_DISCLOSED; exhibits attached but content unspecified

17-12-2025

Tenax Therapeutics, Inc. filed an 8-K on December 17, 2025, disclosing 'Other Events' under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the event, transaction value, or financial impacts are provided in the filing summary. Analysis limited by absence of core event description.

• ·8-K items: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits); multi-item filing.
• ·Voluntary disclosure under Item 8.01; timing compliant (filed same day as dated).
• ·All quantitative data (transaction value, share count, financial metrics) NOT_DISCLOSED.

17-12-2025

Crinetics Pharmaceuticals, Inc. filed a Form 8-K on December 17, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). Item 9.01 references financial statements and exhibits. No specific details on the officer, position, reason, or nature of change (e.g., resignation, appointment) are provided in the summary.

• ·Item 5.02 filing indicates officer-related event (departure, election, appointment, or compensatory arrangements)
• ·Filed timely on 2025-12-17 per SEC 8-K requirements (within 4 business days)
• ·No quantitative data (e.g., share counts, transaction values) or specifics (names, positions, reasons) disclosed

17-12-2025

Star Equity Holdings, Inc. filed an 8-K on December 17, 2025 (AccNo: 0001210708-25-000154), reporting entry into a material definitive agreement under Item 1.01 and including financial statements/exhibits under Item 9.01. No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. Analysis is limited to filing structure, indicating a potentially significant but undefined event.

• ·Items reported: 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits); multi-item filing
• ·Mandatory disclosure for material events; timing compliance NOT_DISCLOSED (filed same day as event date)
• ·Core event: Entry into material definitive agreement; all quantitative data (value, shares, metrics) NOT_DISCLOSED
• ·No revenue/earnings impacts, balance sheet effects, or guidance changes specified

17-12-2025

CVB Financial Corp filed an 8-K on December 17, 2025, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the disclosed information, transaction, or financial metrics are provided in the filing summary. Analysis is limited to filing structure; core event and impacts are NOT_DISCLOSED.

• ·Multi-item 8-K: Items 7.01 (voluntary Reg FD disclosure) and 9.01 (exhibits).
• ·Filed same day as event date; timing compliance within 4 business hours NOT_DISCLOSED.
• ·No quantitative data (transaction value, shares, metrics) or core event details extracted.

17-12-2025

Constellation Energy Corp filed a Form 8-K on December 17, 2025, reporting under Item 8.01 Other Events. No specific details on the event, transaction, or financial impacts are provided in the filing summary. Analysis is limited to metadata due to lack of content.

• ·Item 8.01: Other Events reported
• ·Single-item filing
• ·Filed 2025-12-17; timing compliance NOT_DISCLOSED

18-12-2025

Athira Pharma, Inc. filed a Form 8-K on 2025-12-18 (AccNo: 0001193125-25-323692) reporting Items 1.01 (Entry into Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific transaction details, values, or financial metrics disclosed in the provided summary. Potential implications include strategic agreements and equity dilution, pending full filing review.

• ·Multi-item 8-K: Items 1.01, 3.02, 7.01, 8.01, 9.01.
• ·Core items suggest material agreement and unregistered equity sales.
• ·Filed on 2025-12-18; timing appears compliant (within 4 business days requirement, exact event timing NOT_DISCLOSED).

18-12-2025

PSQ Holdings, Inc. filed a Form 8-K on December 18, 2025, reporting Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific event details, transaction values, or financial metrics are disclosed in the provided summary. Analysis is limited to filing metadata, with all quantitative data as NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 7.01, 8.01, 9.01
• ·Filed December 18, 2025; timing compliance NOT_DISCLOSED
• ·Voluntary/mandatory status unclear without event details

18-12-2025

Comerica Inc filed an 8-K on December 18, 2025, reporting under Item 8.01 Other Events. No specific details on the event, transaction value, or financial impacts are disclosed in the provided filing summary. Analysis is limited to metadata, with all substantive content marked as NOT_DISCLOSED.

• ·Single-item 8-K filing under Item 8.01 (Other Events).
• ·Voluntary disclosure of unspecified event; timing compliance unknown.
• ·No quantitative data (e.g., transaction value, shares, financial metrics) or core event details provided.

18-12-2025

Incannex Healthcare Inc. filed an 8-K on December 18, 2025, under Item 8.01 (Other Events). No details on the specific event, transaction, or financial impacts are disclosed in the provided filing summary. Analysis limited to metadata; core content absent.

• ·Single-item 8-K filing: Item 8.01 Other Events
• ·Filed 2025-12-18 (timing compliance NOT_DISCLOSED)
• ·No quantitative data (e.g., transaction value, shares: NOT_DISCLOSED); voluntary disclosure typical for 8.01

18-12-2025

filed DEFM14A on December 18, 2025 - Filed: 2025-12-18 AccNo: 0001193125-25-323606 Size: 3 MB

• ·Filing Type: DEFM14A
• ·Priority: MEDIUM
• ·Filed: 2025-12-18 AccNo: 0001193125-25-323606 Size: 3 MB

18-12-2025

Brand Engagement Network Inc. filed a Form 8-K on 2025-12-18 reporting Items 1.01 (Material Definitive Agreement), 2.03 (Direct Financial Obligation), 3.02 (Unregistered Equity Sales), 8.01 (Other Events), and 9.01 (Exhibits). No transaction details, values, or impacts are disclosed in the summary. Full filing review required for assessment.

• ·Multi-item mandatory 8-K filing covering agreement, financial obligation, equity sales, and other events.
• ·Quantitative data (transaction value, share count, financial metrics): NOT_DISCLOSED.
• ·Timing compliance and core event details: NOT_DISCLOSED.

18-12-2025

Artificial Intelligence Technology Solutions Inc. filed an 8-K on 2025-12-18 disclosing Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits). No specific event details, transaction values, or financial data are provided in the filing summary. Analysis is limited to metadata with all core event information NOT_DISCLOSED.

• ·Specific Items: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item filing; voluntary disclosure under Item 8.01 likely
• ·Timing and core event details NOT_DISCLOSED; no quantitative data extracted

18-12-2025

Performance Food Group Co filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers), along with Regulation FD Disclosure (Item 7.01) and exhibits (Item 9.01). No specific details on the officer's position, appointment/resignation status, reason, or quantitative data are provided in the filing summary. Analysis is limited due to lack of explicit filing content.

• ·Item 5.02 discloses officer change event, but key details (position, type, reason) NOT_DISCLOSED
• ·Item 7.01 includes Regulation FD Disclosure; content NOT_DISCLOSED
• ·No quantitative data (transaction values, shares, percentages, financial metrics) extracted; all NOT_DISCLOSED

18-12-2025

BeOne Medicines Ltd. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). No specific details on the officer position, name, appointment/resignation status, or reasons are provided in the filing summary. Analysis is severely limited by absence of key facts, resulting in neutral investment implications.

• ·Item 5.02 disclosure confirms an officer or director change event.
• ·Filing date: December 18, 2025; AccNo: 0001651308-25-000151.
• ·No quantitative data (transaction values, shares, percentages, financial metrics) or qualitative details (position, reason, internal/external) disclosed.

18-12-2025

CANNAPHARMARX, INC. filed a Form 8-K on December 18, 2025, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the events, transactions, or exhibits are provided in the filing summary. Analysis is limited to structural elements with all quantitative and event specifics NOT_DISCLOSED.

• ·Items reported: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item filing; voluntary disclosure under Item 8.01
• ·No core event details, dollar values, or financial metrics disclosed

18-12-2025

Gray Media, Inc. filed an 8-K on December 18, 2025, under Item 8.01 Other Events. No details on the core event, transaction value, or financial impacts are disclosed in the provided filing summary. Analysis is limited to metadata, indicating a voluntary disclosure of unspecified events.

• ·Single-item filing: Item 8.01 (Other Events)
• ·Voluntary disclosure; no mandatory trigger specified
• ·No quantitative data (e.g., transaction value, share count: NOT_DISCLOSED)

18-12-2025

Kyverna Therapeutics, Inc. filed a Form 8-K on December 18, 2025 (AccNo: 0001213900-25-123033), disclosing entry into a material definitive agreement (Item 1.01), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific details on the agreement, transaction value, or financial impacts are provided in the summary. This multi-item filing signals a potentially significant development but lacks data for directional assessment.

• ·Multi-item 8-K: Items 1.01, 8.01, 9.01 reported.
• ·Core event: Entry into Material Definitive Agreement (mandatory disclosure).
• ·All quantitative data (transaction value, shares, financial metrics): NOT_DISCLOSED.

18-12-2025

Aspen Aerogels Inc. filed an 8-K on December 18, 2025, reporting entry into a Material Definitive Agreement (Item 1.01), Regulation FD Disclosure (Item 7.01), and Financial Statements and Exhibits (Item 9.01). No specific details on the agreement, transaction value, or disclosures are provided in the summary. Analysis is limited to filing structure due to lack of filing content.

• ·Multi-item 8-K filing: Items 1.01, 7.01, 9.01
• ·Core event: Entry into Material Definitive Agreement (details NOT_DISCLOSED)
• ·All quantitative data (transaction value, shares, financial metrics) NOT_DISCLOSED

18-12-2025

filed 8-K/A on December 18, 2025 - Filed: 2025-12-18 AccNo: 0001193125-25-323395 Size: 916 KB Item 9.01: Financial Statements and Exhibits

• ·Filing Type: 8-K/A
• ·Priority: MEDIUM
• ·Filed: 2025-12-18 AccNo: 0001193125-25-323395 Size: 916 KB Item 9
• ·01: Financial Statements and Exhibits

18-12-2025

Avidity Biosciences, Inc. filed a Form 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment), other events under Item 8.01, and exhibits under Item 9.01. No specific details on the officer position, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Analysis is limited due to lack of explicit content.

• ·Item 5.02 discloses officer change; specifics NOT_DISCLOSED
• ·Filed 2025-12-18 per SEC requirements
• ·No numerical values, names, or reasons stated

18-12-2025

Idaho Copper Corp filed a Form 8-K on December 18, 2025, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the event, transaction, or exhibits are disclosed in the provided summary. Analysis limited to filing structure; core event content NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 8.01 (voluntary Other Events) and 9.01 (exhibits attached).
• ·No quantitative data (transaction value, shares, financial metrics) or event details extracted: all NOT_DISCLOSED.
• ·Compliance with 8-K timing cannot be assessed without event date; appears standard filing.

18-12-2025

ONE Gas, Inc. filed an 8-K on December 18, 2025, reporting under Item 8.01 Other Events. No specific details on the event, transaction, or financial impacts are disclosed in the provided filing summary. Analysis limited to metadata; core event undisclosed.

• ·Single-item 8-K filing under Item 8.01 (Other Events)
• ·Filed 2025-12-18; timing compliance NOT_DISCLOSED
• ·No quantitative data, financial metrics, or event description provided

18-12-2025

VSEE Health, Inc. filed an 8-K on December 18, 2025, reporting under Item 5.03 amendments to Articles of Incorporation or Bylaws or a change in fiscal year, with exhibits under Item 9.01. No specific details on the amendments or changes are disclosed in the provided filing summary. Quantitative data and transaction details are NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 5.03 (governance amendments/fiscal year change) and 9.01 (exhibits)
• ·Core event: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year (details NOT_DISCLOSED)
• ·No numerical values, financial impacts, or strategic context provided

18-12-2025

Helix Energy Solutions Group Inc filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02, along with Regulation FD disclosure (Item 7.01) and exhibits (Item 9.01). No specific details on the officer's position, appointment/resignation, reasons, or quantitative data are provided in the summary. Analysis is limited to filing metadata, indicating a routine SEC disclosure without directional implications.

• ·Item 5.02: Departure of directors/officers, election/appointment of directors/officers, or compensatory arrangements
• ·Item 7.01: Regulation FD disclosure
• ·Item 9.01: Financial statements and exhibits filed

18-12-2025

Cambium Networks Corp filed an 8-K on December 18, 2025, reporting a notice of delisting or failure to satisfy continued listing rules (Item 3.01) and departure of directors or certain officers (Item 5.02), with exhibits under Item 9.01. This is a multi-item mandatory disclosure signaling significant listing and governance issues. No financial metrics, transaction values, or detailed event descriptions are provided in the filing summary.

• ·Items reported: 3.01 (Delisting notice), 5.02 (Director/officer departures), 9.01 (Exhibits)
• ·Multi-item filing; mandatory disclosures
• ·Filed same day as event date (2025-12-18), likely within 4-business-day requirement

18-12-2025

Darden Restaurants Inc filed an 8-K on December 18, 2025, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction values, or quantitative data are disclosed in the provided summary. Analysis is limited to filing structure with all key details marked as NOT_DISCLOSED.

• ·8-K items: 2.02 and 9.01 (multi-item filing)
• ·Core event: Financial results announcement
• ·No revenue, EPS, or other metrics provided (NOT_DISCLOSED)

18-12-2025

Avadel Pharmaceuticals PLC filed a Form 8-K on December 18, 2025, under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on events, transactions, or financials are provided in the summary. Analysis limited to filing structure; core content NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 7.01, 8.01, 9.01
• ·Likely voluntary disclosure (Reg FD and Other Events)
• ·Exhibits attached per Item 9.01; no quantitative data extracted (all NOT_DISCLOSED)

18-12-2025

HBT Financial, Inc. filed an 8-K on December 18, 2025, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the event, transaction, or financial metrics are disclosed in the provided summary. Analysis is severely limited by absence of filing content.

• ·Specific Items: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits) - multi-item filing
• ·No quantitative data (e.g., transaction value, share count, financial metrics) extracted: all NOT_DISCLOSED
• ·Voluntary/mandatory status, timing compliance, and core event details NOT_DISCLOSED

18-12-2025

Pyxis Oncology, Inc. filed an 8-K on December 18, 2025, reporting under Items 7.01 (Regulation FD Disclosure) and 8.01 (Other Events). No specific details on the core event, transaction, or financial impacts are disclosed in the provided filing summary. Analysis is limited to filing structure due to lack of substantive content.

• ·Multi-item 8-K filing: Items 7.01 and 8.01.
• ·Regulation FD Disclosure (7.01) suggests voluntary update or press release.
• ·Other Events (8.01) indicates unspecified material event; all quantitative data NOT_DISCLOSED.

18-12-2025

MAXIMUS, INC. filed a Form 8-K on December 18, 2025, disclosing an event under Item 5.02 related to departure of directors or certain officers, election or appointment of directors/officers, or compensatory arrangements. No specific details on positions affected, individuals involved, reasons for change, or quantitative data are provided in the filing summary. This represents a routine SEC disclosure with limited actionable information.

• ·Item 5.02 disclosure for officer/director changes or compensatory arrangements
• ·Filed timely on 2025-12-18 per SEC requirements
• ·All specifics (position, appointment/resignation, reasons) NOT_DISCLOSED

18-12-2025

FuelCell Energy Inc filed an 8-K on 2025-12-18 with Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific numerical data or details in the summary. Analysis limited to filing metadata; core content NOT_DISCLOSED.

• ·Specific Items: 2.02, 7.01, 9.01 (multi-item filing)
• ·Event: Financial results announcement via voluntary 8-K
• ·No quantitative data (revenue, EPS, etc.) or transaction details disclosed

18-12-2025

BKV Corp filed a Form 8-K on December 18, 2025, disclosing under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits). No specific details on the event, transaction, or exhibits are provided in the filing summary. Analysis is limited due to lack of substantive content.

• ·Multi-item 8-K filing: Items 8.01 and 9.01 reported.
• ·Item 8.01 indicates voluntary disclosure of an unspecified 'Other Event'.
• ·All quantitative data (transaction value, shares, financial metrics) NOT_DISCLOSED.

18-12-2025

MPLX LP filed an 8-K on December 18, 2025, under Item 5.02 disclosing a change involving departure of directors/officers, election/appointment of directors/officers, or compensatory arrangements. No specific details on positions affected, individuals, reasons, or quantitative data are provided in the filing summary. Analysis limited to header information only.

• ·Item 5.02 filing indicates officer/director change or compensatory arrangement, but key details NOT_DISCLOSED.
• ·No information on appointment/resignation, internal/external hire, reasons, or timing provided.
• ·No quantitative data extracted: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED.

18-12-2025

Marathon Petroleum Corp filed a Form 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment; Compensatory Arrangements), along with Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on positions, individuals, reasons, or quantitative data are provided in the summary. Analysis is limited to filing structure and triggered items, with all key change details NOT_DISCLOSED.

• ·Item 5.02 triggered for officer/director departure, election, appointment, or compensatory arrangements
• ·Filed timely on 2025-12-18 per SEC 8-K requirements (within 4 business days)
• ·Items 8.01 and 9.01 indicate additional events and exhibits, but contents NOT_DISCLOSED

18-12-2025

Core Natural Resources, Inc. filed a Form 8-K on December 18, 2025, under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). No specific content, events, transactions, or financial data is disclosed in the provided summary. Analysis limited to filing structure; all quantitative details NOT_DISCLOSED.

• ·Items reported: 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits); multi-item filing.
• ·Regulation FD suggests voluntary disclosure of potentially material information.
• ·Exhibits mentioned but content and details NOT_DISCLOSED.

18-12-2025

NexMetals Mining Corp. filed a Form 8-K on December 18, 2025, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the events, transactions, or exhibits are disclosed in the provided filing summary. Analysis is limited to metadata, with all core event facts NOT_DISCLOSED.

• ·Multi-item 8-K: Items 8.01 and 9.01 reported
• ·Filing date: 2025-12-18; timing compliance and event details NOT_DISCLOSED
• ·Voluntary disclosure likely (Item 8.01); no quantitative data or transaction specifics provided

18-12-2025

Myseum, Inc. filed an 8-K on December 18, 2025, disclosing under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the event, transaction, or financials are provided in the filing summary. Analysis is limited to filing structure; core event details are NOT_DISCLOSED.

• ·Reported Items: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits); multi-item filing.
• ·Timing and compliance: Filed on 2025-12-18; timeliness within 4 business days cannot be confirmed without market holiday data (NOT_DISCLOSED).
• ·Quantitative data: All metrics (transaction value, share count, percentages, financials) NOT_DISCLOSED.

18-12-2025

CarMax Inc filed an 8-K on 2025-12-18 disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits under Item 9.01. No specific financial metrics, transaction details, or quantitative data are provided in the filing summary. Analysis is limited to filing structure; full document review required for substantive insights.

• ·Items reported: 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item 8-K filing; timing compliance and voluntary/mandatory status NOT_DISCLOSED
• ·Core event: Financial results announcement; all quantitative data (revenue, EPS, etc.) NOT_DISCLOSED

18-12-2025

Camp4 Therapeutics Corp filed an 8-K on December 18, 2025, disclosing entry into a material definitive agreement (Item 1.01), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific details on the agreement, transaction value, or financial impacts are provided in the filing summary. Analysis limited to disclosed items; all other data NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 1.01, 7.01, 9.01 reported.
• ·Core event: Entry into material definitive agreement (FACT), but terms NOT_DISCLOSED.
• ·Mandatory disclosure under SEC rules; timing compliance NOT_DISCLOSED.

18-12-2025

American Water Works Company, Inc. filed an 8-K on December 18, 2025, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the event, transaction, or exhibits are provided in the filing summary. Insufficient information to assess materiality, financial impact, or market reaction.

• ·Multi-item 8-K filing: Items 8.01 (Other Events) and 9.01 (Exhibits)
• ·Voluntary disclosure under Item 8.01; core event details NOT_DISCLOSED
• ·No quantitative data (transaction value, shares, financial metrics) mentioned: all NOT_DISCLOSED

18-12-2025

TERAWULF INC. filed a Form 8-K on December 18, 2025, reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with a 3 MB size, but specific event details, transaction values, or financial metrics are NOT_DISCLOSED in the provided summary. Analysis limited to filing metadata; core content unavailable.

• ·Multi-item 8-K: Items 7.01, 8.01, 9.01 reported
• ·Voluntary disclosure likely for Reg FD and Other Events; timing compliance unknown (must be within 4 business days)
• ·No quantitative data (e.g., transaction value, shares, financial metrics) or core event details disclosed

18-12-2025

Pulmatrix, Inc. filed a Form 8-K on December 18, 2025, reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific event details, financial data, or transaction information are disclosed in the provided filing summary.

• ·Multi-item 8-K filing: Items 7.01, 8.01, and 9.01.
• ·Regulation FD disclosure and other events reported; exhibits attached.
• ·No quantitative data, core event, or financial impacts specified (all NOT_DISCLOSED).

18-12-2025

Alight, Inc. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment), alongside Regulation FD Disclosure (Item 7.01) and Financial Statements/Exhibits (Item 9.01). No specific details on the officer's position, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Analysis is limited to disclosure of a leadership event without substantive content.

• ·Item 5.02 filing signals officer departure, election, appointment, or compensatory arrangements - specifics NOT_DISCLOSED
• ·Item 7.01 includes Regulation FD Disclosure - content NOT_DISCLOSED
• ·Item 9.01 lists exhibits - details NOT_DISCLOSED; no financial metrics or transaction values extracted

18-12-2025

GlobalTech Corp filed an 8-K on December 18, 2025 (AccNo: 0001477932-25-009036), announcing completion of an acquisition or disposition of assets (Item 2.01) and unregistered sales of equity securities (Item 3.02). Additional disclosures include Regulation FD information (Item 7.01) and financial statements/exhibits (Item 9.01). No specific deal structure, parties, valuation, or quantitative details are disclosed.

• ·Item 2.01 confirms completion of acquisition or asset disposition
• ·Item 3.02 discloses unregistered sales of equity securities
• ·Item 7.01 provides Regulation FD disclosure
• ·Item 9.01 includes financial statements and exhibits; details NOT_DISCLOSED

18-12-2025

Dragonfly Energy Holdings Corp. filed an 8-K on 2025-12-18 disclosing Items 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), and 9.01 (Financial Statements and Exhibits). No specific details on the modifications, amendments, or exhibits are provided in the summary. Analysis is limited; all quantitative data and event specifics are NOT_DISCLOSED.

• ·Multi-item 8-K filing covering governance changes (3.03, 5.03) and exhibits (9.01).
• ·Core event involves material modifications to security holder rights and corporate amendments; transaction value, share count, and financial metrics NOT_DISCLOSED.
• ·Filing timing and compliance cannot be assessed without full details; no revenue, balance sheet, or guidance impacts stated.

18-12-2025

Cardlytics, Inc. filed an 8-K on December 18, 2025, reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with Regulation FD Disclosure in Item 7.01 and exhibits in Item 9.01. No specific details on the officer, position, appointment/resignation, reasons, or quantitative data are disclosed in the provided filing summary. Analysis limited to filing structure; all key facts such as names, roles, and impacts are NOT_DISCLOSED.

• ·Item 5.02 discloses officer change event without specifics on key position (e.g., CEO/CFO) or nature (appointment/resignation)
• ·Item 7.01 includes Regulation FD Disclosure, potentially material non-public information
• ·No quantitative data extracted: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED

18-12-2025

Ategrity Specialty Insurance Co Holdings filed a Form 8-K on December 18, 2025, reporting under Item 7.01 Regulation FD Disclosure (Accession No. 0002040491-25-000020, 157 KB). This is a voluntary disclosure with no specific event details, transaction values, or quantitative data provided in the filing summary. Analysis is limited to metadata; core content not disclosed.

• ·Single-item filing: Item 7.01 (Regulation FD Disclosure)
• ·Voluntary disclosure; timing compliance unknown without event date
• ·No quantitative data (e.g., transaction value, financial metrics: NOT_DISCLOSED)
• ·Sector not specified; no material event details available

18-12-2025

Trump Media & Technology Group Corp. filed a Form 8-K on December 18, 2025, under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). No core event details, transaction values, financial metrics, or quantitative data are disclosed in the provided filing summary. Analysis is constrained to filing structure, indicating a potential voluntary material information release with attached exhibits.

• ·Multi-item 8-K: Items 7.01 and 9.01 reported.
• ·Item 7.01 suggests Regulation FD compliance for material non-public info.
• ·Item 9.01 indicates exhibits attached, content NOT_DISCLOSED.

18-12-2025

Sprinklr, Inc. filed a Form 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment), along with Regulation FD disclosure (Item 7.01) and exhibits (Item 9.01). Specific details on the officer position, nature of change (appointment/resignation), reasons, or quantitative data are NOT_DISCLOSED. Analysis limited to filing items; no facts on leadership impact or market reaction available.

• ·Item 5.02: Officer change event (details NOT_DISCLOSED)
• ·Item 7.01: Regulation FD disclosure (content NOT_DISCLOSED)
• ·Item 9.01: Financial statements and exhibits filed
• ·No quantitative data (shares, values, percentages: NOT_DISCLOSED)

18-12-2025

DIRTT Environmental Solutions Ltd filed a Form 8-K on December 18, 2025, reporting Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific content, transaction details, or numerical data is disclosed in the provided summary. Analysis is limited to filing structure; all event specifics are NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 7.01, 8.01, 9.01
• ·Filed December 18, 2025 (timing relative to events NOT_DISCLOSED)
• ·Voluntary/mandatory status and core events NOT_DISCLOSED

18-12-2025

Werewolf Therapeutics, Inc. filed an 8-K on December 18, 2025, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the event, transaction value, or financial metrics are disclosed in the provided filing summary. Analysis limited to disclosed items; core event content NOT_DISCLOSED.

• ·Items reported: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits) - multi-item filing.
• ·Voluntary disclosure under 8.01; timing compliance NOT_DISCLOSED.
• ·Quantitative data (transaction value, share count, percentages, financial metrics): all NOT_DISCLOSED.

18-12-2025

Amaze Holdings, Inc. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the officer, position, appointment/resignation, or reasons are provided in the filing summary. Quantitative data such as transaction values, share counts, or financial metrics are NOT_DISCLOSED.

• ·Item 5.02 indicates a leadership change event (officer departure, election, or appointment), but key details like position (e.g., CEO/CFO) and nature (resignation/appointment) are NOT_DISCLOSED.
• ·Includes Regulation FD disclosure (Item 7.01) and exhibits (Item 9.01), suggesting potential additional material information.
• ·Filed timely per SEC 8-K requirements; sector NOT_DISCLOSED.

18-12-2025

Data Storage Corp filed a Form 8-K on December 18, 2025, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the event, transaction, or exhibits are disclosed in the provided filing summary. This is a multi-item filing with limited visible content.

• ·Specific Items: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits)
• ·Filing date: 2025-12-18, AccNo: 0001731122-25-001689
• ·No quantitative data, event details, or financial metrics extracted (all NOT_DISCLOSED)

18-12-2025

Interactive Strength, Inc. filed a Form 8-K on December 18, 2025, disclosing Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), 3.02 (Unregistered Sales of Equity Securities), and 8.01 (Other Events). This is a multi-item filing with no specific transaction details, dollar values, or quantitative data provided in the summary. Analysis limited to item descriptions; core event and impacts NOT_DISCLOSED.

• ·Multi-item 8-K: Items 1.01, 2.03, 3.02, 8.01 reported.
• ·Timing: Filed 2025-12-18; compliance with 4-business-day window NOT_DISCLOSED.
• ·All quantitative data (transaction value, share count, financial metrics) NOT_DISCLOSED.

18-12-2025

CION Investment Corp filed a Form 8-K on December 18, 2025, reporting Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure of a material event, but specific details on the agreement, obligation size, or impacts are NOT_DISCLOSED. Analysis is limited to item descriptions with no quantitative data provided.

• ·Multi-item 8-K: Items 1.01, 2.03, 9.01 reported
• ·Core event: Entry into material agreement and new financial obligation
• ·No transaction value, financial metrics, or strategic details disclosed

18-12-2025

Picard Medical, Inc. filed an 8-K on December 18, 2025, disclosing under Item 7.01 (Regulation FD) and Item 9.01 (Financial Statements and Exhibits). No specific event details, transaction values, or financial metrics are provided in the summary. Critical filing content is missing, limiting analysis to form structure only.

• ·Multi-item 8-K filing: Items 7.01 (voluntary Reg FD disclosure) and 9.01 (exhibits).
• ·No core event, dollar values, or quantitative data disclosed.
• ·Timing compliance and materiality cannot be assessed without full filing content.

18-12-2025

Kindly MD, Inc. filed a Form 8-K on December 18, 2025, disclosing Items 5.07 (Submission of Matters to a Vote of Security Holders), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on events, transactions, or financial metrics are provided in the filing summary. Analysis is limited to item disclosures; core events and impacts are NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 5.07, 7.01, 8.01, 9.01.
• ·Timing compliance unknown; filed within standard 4 business days window presumed but unconfirmed.
• ·No quantitative data (transaction values, shares, financial metrics) disclosed.

18-12-2025

Energy Services of America CORP filed a Form 8-K on December 18, 2025, disclosing an event under Item 8.01 (Other Events). No details on the core event, financial impacts, or quantitative metrics are provided in the filing summary. Analysis limited to metadata; all specifics NOT_DISCLOSED.

• ·Single-item 8-K filing under Item 8.01: Other Events
• ·Filed 2025-12-18 (AccNo: 0001104659-25-122338); timing compliance unknown
• ·No transaction values, financial metrics, or strategic details extracted (all NOT_DISCLOSED)

18-12-2025

Treace Medical Concepts, Inc. filed a multi-item 8-K on December 18, 2025 (AccNo: 0001193125-25-323802), reporting entry into (Item 1.01) and termination of (Item 1.02) material definitive agreements, creation of a direct financial obligation (Item 2.03), material modifications to security holders' rights (Item 3.03), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and exhibits (Item 9.01). No specific transaction values, financial metrics, or details are disclosed in the provided summary. This indicates significant corporate developments, but analysis is limited without full filing content.

• ·Multi-item mandatory 8-K filing covering agreements, financial obligations, and security holder rights changes
• ·Filed on event date (2025-12-18), likely within 4-business-day requirement
• ·All quantitative data (transaction value, share count, percentages) NOT_DISCLOSED

18-12-2025

SR Bancorp, Inc. filed a Form 8-K on December 18, 2025, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the other event or contents of exhibits are disclosed in the provided filing summary. Analysis is limited to filing metadata with all event specifics and quantitative data marked as NOT_DISCLOSED.

• ·Items reported: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item voluntary 8-K filing; timing compliance NOT_DISCLOSED
• ·No core event details, transaction values, financial metrics, or quantitative data disclosed

18-12-2025

eHealth, Inc. filed a multi-item Form 8-K on December 18, 2025, reporting Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details, transaction values, or financial impacts are disclosed in the provided filing summary. Analysis is limited to item descriptions, indicating potential governance changes and voluntary information disclosure.

• ·Multi-item 8-K filing: Items 5.03, 7.01, 9.01
• ·Item 5.03 suggests amendments to governing documents or fiscal year change (mandatory if material)
• ·Item 7.01 indicates Regulation FD disclosure (typically voluntary)
• ·Item 9.01 lists financial statements/exhibits; content NOT_DISCLOSED

18-12-2025

Ovid Therapeutics Inc. filed an 8-K on December 18, 2025, under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits). No details on the specific event, transaction, or exhibits are disclosed in the provided summary. Analysis is severely limited by absence of filing content.

• ·Items reported: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits); multi-item filing.
• ·Core event, financials, and quantitative data: NOT_DISCLOSED.
• ·Timing, materiality, and impacts: NOT_DISCLOSED due to lack of filing details.

18-12-2025

Greenpro Capital Corp. filed a Form 8-K on December 18, 2025, reporting entry into a material definitive agreement (Item 1.01) and unregistered sales of equity securities (Item 3.02), with exhibits under Item 9.01. No specific transaction details, values, or financial impacts are disclosed in the provided summary. This multi-item filing signals potentially material developments, but analysis is limited without full filing content.

• ·Multi-item 8-K: Items 1.01, 3.02, 9.01 reported.
• ·Core events involve material agreement and unregistered equity sales; all quantitative data NOT_DISCLOSED.
• ·Filed same day as event; compliance with 4-business-day window presumed but unverified.

18-12-2025

Liberty Global Ltd. filed an 8-K on December 18, 2025, reporting Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific event details, transaction values, or financial metrics are disclosed in the provided filing summary. Analysis is limited to filing structure; content review required for materiality assessment.

• ·Multi-item 8-K filing: Items 7.01 (voluntary Reg FD) and 9.01 (exhibits).
• ·No core event, dollar values, or quantitative data explicitly stated.
• ·Timing compliance and strategic context NOT_DISCLOSED.

18-12-2025

PureCycle Technologies, Inc. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements). No specific details on position, individual, reason, or quantitative data are provided in the summary. Item 9.01 references financial statements and exhibits, but content is NOT_DISCLOSED.

• ·Item 5.02 filing indicates unspecified officer change, appointment, or compensatory arrangement.
• ·No names, positions (e.g., CEO/CFO), reasons (e.g., resignation/retirement), or timing details disclosed.
• ·Quantitative data extraction: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED.

18-12-2025

Avantor, Inc. filed a Form 8-K on December 18, 2025, disclosing an officer change under Item 5.02, Regulation FD disclosure under Item 7.01, and financial statements/exhibits under Item 9.01. No specific details on the officer position, appointment/resignation, reasons, or quantitative data are provided in the filing summary. Analysis limited to disclosed items; critical details NOT_DISCLOSED.

• ·Item 5.02 indicates departure, election, or appointment of certain officers; specifics NOT_DISCLOSED
• ·Item 7.01: Regulation FD Disclosure; content NOT_DISCLOSED
• ·Item 9.01: Financial Statements and Exhibits; details NOT_DISCLOSED

18-12-2025

Cartesian Growth Corp III filed a Form 8-K on December 18, 2025, reporting Items 1.01 (Entry into Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific transaction details, dollar values, or quantitative data are disclosed in the provided summary. Analysis is limited to filing structure; core event and impacts are NOT_DISCLOSED.

• ·Multi-item mandatory 8-K filing (Items 1.01, 3.02, 7.01, 9.01); filing date aligns with event but intra-day timing NOT_DISCLOSED.
• ·Core event involves material definitive agreement and unregistered equity sales; strategic importance and financial impacts NOT_DISCLOSED.
• ·No quantitative data extracted: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED.

18-12-2025

Cintas Corp filed an 8-K on 2025-12-18 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. No specific financial metrics, transaction details, or quantitative data are provided in the filing summary. This is a standard multi-item filing for earnings-related disclosures.

• ·Items reported: 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item filing; timing compliance NOT_DISCLOSED
• ·No revenue, earnings, transaction values, or other quantitative data disclosed

18-12-2025

DiaMedica Therapeutics Inc. filed an 8-K on December 18, 2025, reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on events, transactions, or financials are disclosed in the provided filing summary. Analysis is limited to filing structure; core content NOT_DISCLOSED.

• ·Multi-item 8-K filing (7.01, 8.01, 9.01); voluntary disclosures typical for these items.
• ·No quantitative data (transaction value, shares, financial metrics) extracted: all NOT_DISCLOSED.
• ·Timing compliance and event details NOT_DISCLOSED; no material event facts available.